Q2 2024 --06-30 false 0000050471 0 0 3 00000504712023-10-012023-12-31 thunderdome:item iso4217:USD 0000050471trak:SeriesB1PreferredStockMember2023-10-012023-12-31 0000050471us-gaap:ServiceAgreementsMembertrak:FMIMember2022-10-012022-12-31 0000050471us-gaap:ServiceAgreementsMembertrak:FMIMember2023-10-012023-12-31 0000050471us-gaap:RelatedPartyMember2022-12-31 0000050471us-gaap:RelatedPartyMember2023-12-31 0000050471trak:ShareRepurchaseProgramMember2023-12-31 xbrli:shares 0000050471trak:ShareRepurchaseProgramMember2023-10-012023-12-31 iso4217:USDxbrli:shares 0000050471trak:ShareRepurchaseProgramMember2023-09-30 0000050471trak:ShareRepurchaseProgramMember2023-07-012023-09-30 00000504712023-07-012023-09-30 00000504712023-12-31 00000504712019-05-202023-12-31 00000504712022-05-102022-05-10 00000504712021-08-312021-08-31 00000504712021-08-31 00000504712021-05-18 00000504712021-05-182021-05-18 00000504712019-05-09 0000050471trak:SeriesB1PreferredStockMember2023-12-31 00000504712023-12-312023-12-31 0000050471us-gaap:SeriesBPreferredStockMember2023-12-31 00000504712023-08-29 00000504712023-07-012023-12-31 0000050471trak:SeriesBAndSeriesB1PreferredStockMember2023-12-31 0000050471trak:SeriesBAndSeriesB1PreferredStockMember2023-10-012023-12-31 0000050471trak:SeriesBAndSeriesB1PreferredStockMember2023-09-30 0000050471trak:SeriesBAndSeriesB1PreferredStockMember2023-07-012023-09-30 xbrli:pure 0000050471us-gaap:SeriesBPreferredStockMember2023-10-012023-12-31 0000050471trak:BlankCheckMember2023-12-31 utr:Y 0000050471trak:ExercisePriceTenDollarsMaximumMember2023-07-012023-12-31 0000050471trak:ExercisePriceTenDollarsMaximumMember2023-12-31 0000050471trak:ExercisePriceFourDollarsMinimumMember2023-07-012023-12-31 0000050471trak:ExercisePriceFourDollarsMinimumMember2023-12-31 0000050471us-gaap:RestrictedStockUnitsRSUMembertrak:VestedAndUnissuedMember2023-12-31 0000050471us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2023-12-31 0000050471us-gaap:RestrictedStockUnitsRSUMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2023-07-012023-12-31 0000050471us-gaap:ShareBasedPaymentArrangementNonemployeeMember2023-07-012023-12-31 0000050471us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2023-06-30 00000504712022-07-012022-12-31 00000504712022-10-012022-12-31 0000050471srt:MaximumMember2022-12-31 0000050471srt:MaximumMember2023-12-31 00000504712022-10-012023-12-31 0000050471trak:ProfessionalServicesMember2022-07-012022-12-31 0000050471trak:ProfessionalServicesMember2023-07-012023-12-31 0000050471trak:ProfessionalServicesMember2022-10-012022-12-31 0000050471trak:ProfessionalServicesMember2023-10-012023-12-31 0000050471trak:SubscriptionAndSupportMember2022-07-012022-12-31 0000050471trak:SubscriptionAndSupportMember2023-07-012023-12-31 0000050471trak:SubscriptionAndSupportMember2022-10-012022-12-31 0000050471trak:SubscriptionAndSupportMember2023-10-012023-12-31 00000504712023-06-30 00000504712022-12-31 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-31 0000050471us-gaap:RetainedEarningsMember2022-12-31 0000050471us-gaap:AdditionalPaidInCapitalMember2022-12-31 0000050471us-gaap:CommonStockMember2022-12-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2022-12-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2022-12-31 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-012022-12-31 0000050471us-gaap:RetainedEarningsMember2022-10-012022-12-31 0000050471us-gaap:AdditionalPaidInCapitalMember2022-10-012022-12-31 0000050471us-gaap:CommonStockMember2022-10-012022-12-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2022-10-012022-12-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2022-10-012022-12-31 00000504712022-09-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-30 0000050471us-gaap:RetainedEarningsMember2022-09-30 0000050471us-gaap:AdditionalPaidInCapitalMember2022-09-30 0000050471us-gaap:CommonStockMember2022-09-30 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2022-09-30 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2022-09-30 00000504712022-07-012022-09-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-30 0000050471us-gaap:RetainedEarningsMember2022-07-012022-09-30 0000050471us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-30 0000050471us-gaap:CommonStockMember2022-07-012022-09-30 00000504712022-06-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-30 0000050471us-gaap:RetainedEarningsMember2022-06-30 0000050471us-gaap:AdditionalPaidInCapitalMember2022-06-30 0000050471us-gaap:CommonStockMember2022-06-30 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2022-06-30 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2022-06-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-31 0000050471us-gaap:RetainedEarningsMember2023-12-31 0000050471us-gaap:AdditionalPaidInCapitalMember2023-12-31 0000050471us-gaap:CommonStockMember2023-12-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-12-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-12-31 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-31 0000050471us-gaap:RetainedEarningsMember2023-10-012023-12-31 0000050471us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-31 0000050471us-gaap:CommonStockMember2023-10-012023-12-31 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-10-012023-12-31 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-10-012023-12-31 00000504712023-09-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-30 0000050471us-gaap:RetainedEarningsMember2023-09-30 0000050471us-gaap:AdditionalPaidInCapitalMember2023-09-30 0000050471us-gaap:CommonStockMember2023-09-30 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-09-30 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-09-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-30 0000050471us-gaap:RetainedEarningsMember2023-07-012023-09-30 0000050471us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-30 0000050471us-gaap:CommonStockMember2023-07-012023-09-30 0000050471us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-30 0000050471us-gaap:RetainedEarningsMember2023-06-30 0000050471us-gaap:AdditionalPaidInCapitalMember2023-06-30 0000050471us-gaap:CommonStockMember2023-06-30 0000050471trak:SeriesB1PreferredStockMemberus-gaap:PreferredStockMember2023-06-30 0000050471us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2023-06-30 0000050471trak:CommonStockToPayAccruedLiabilitiesMember2022-07-012022-12-31 0000050471trak:CommonStockToPayAccruedLiabilitiesMember2023-07-012023-12-31 0000050471trak:SeriesB1PreferredStockMember2023-06-30 0000050471us-gaap:SeriesBPreferredStockMember2023-06-30 0000050471us-gaap:CustomerRelationshipsMember2023-06-30 0000050471us-gaap:CustomerRelationshipsMember2023-12-31 00000504712024-02-14
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended December 31, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the transition period from           to           .

 

Commission File Number 001-34941

 

REPOSITRAK, INC.

(Exact name of small business issuer as specified in its charter)

 

Nevada

37-1454128

(State or other jurisdiction of incorporation or organization)

(IRS Employer Identification No.)

 

5282 South Commerce Drive, Suite D292, Murray, Utah 84107

(Address of principal executive offices)

 

(435) 645-2000

(Registrant’s telephone number)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.01 per share

TRAK

New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities and Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Sec.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

   

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☒ No

 

As of February 14, 2024, 18,209,501 shares of the registrant’s common stock, $0.01 par value, were issued and outstanding.  

 

 

 

   

 

REPOSITRAK, INC.

 

TABLE OF CONTENTS

 

   

Page

PART I - FINANCIAL INFORMATION

     

Item 1.

Financial Statements

1
     
 

Consolidated Condensed Balance Sheets as of December 31, 2023 and June 30, 2023 (Unaudited)

1
  Consolidated Condensed Statements of Operations and Comprehensive Income for the Three and Six Months Ended December 31, 2023 and 2022 (Unaudited) 2
 

Consolidated Condensed Statements of Cash Flows for the Six Months Ended December 31, 2023 and 2022 (Unaudited)

3
 

Consolidated Condensed Statements of Stockholders’ Equity for the Three and Six Months Ended December 31, 2023 and 2022 (Unaudited)

4
 

Notes to Consolidated Condensed Financial Statements

6
     

Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

14
     

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

23
     

Item 4.

Controls and Procedures

24
     

PART II OTHER INFORMATION

     

Item 1.

Legal Proceedings

24
     

Item 1A.

Risk Factors

24
     

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

24
     

Item 3.

Defaults Upon Senior Securities

24
     

Item 5.

Other Information

24
     

Item 6.

Exhibits

24
     

Signatures

25

 

 

 

 

  

 

PART I

 

FINANCIAL INFORMATION

 

ITEM 1.  FINANCIAL STATEMENTS

 

REPOSITRAK, INC.

Consolidated Condensed Balance Sheets (Unaudited)

 

   

December 31,

2023

   

June 30,

2023

 

Assets

               

Current Assets

               

Cash and cash equivalents

  $ 23,253,071     $ 23,990,879  

Receivables, net of allowance for doubtful accounts of $219,163 and $170,103 at December 31, 2023 and June 30, 2023, respectively

    3,799,551       2,523,019  

Contract asset – unbilled current portion

    150,180       186,959  

Prepaid expense and other current assets

    366,766       573,763  

Total Current Assets

    27,569,568       27,274,620  
                 

Property and equipment, net

    716,979       986,300  
                 

Other Assets:

               

Deposits and other assets

    22,414       22,414  

Prepaid expense – less current portion

    8,996       36,282  

Contract asset – unbilled long-term portion

    108,052       108,052  

Operating lease – right-of-use asset

    280,958       310,796  

Customer relationships

    197,100       262,800  

Goodwill

    20,883,886       20,883,886  

Capitalized software costs, net

    541,450       698,281  

Total Other Assets

    22,042,856       22,322,511  
                 

Total Assets

  $ 50,329,403     $ 50,583,431  
                 

Liabilities and Shareholders Equity

               

Current liabilities

               

Accounts payable

  $ 332,306     $ 431,387  

Accrued liabilities

    1,634,620       1,620,000  

Contract liability – deferred revenue

    2,026,565       1,903,001  

Operating lease liability – current

    61,372       58,771  

Notes payable and financing leases – current

    216,542       219,262  

Total current liabilities

    4,271,405       4,232,421  
                 

Long-term liabilities

               

Operating lease liability – less current portion

    231,830       263,047  

Notes payable and financing leases – less current portion

    83,677       206,032  

Total liabilities

    4,586,912       4,701,500  
                 

Commitments and contingencies

           
                 

Stockholders equity:

               
Preferred Stock; $0.01 par value, 30,000,000 shares authorized;                

Series B Preferred, 700,000 shares authorized; 625,375 shares issued and outstanding at December 31, 2023 and June 30, 2023;

    6,254       6,254  

Series B-1 Preferred, 550,000 shares authorized; 142,309 and 212,402 shares issued and outstanding at December 31, 2023 and June 30, 2023, respectively

    1,423       2,124  

Common Stock, $0.01 par value, 50,000,000 shares authorized; 18,158,730 and 18,309,051 issued and outstanding at December 31, 2023 and June 30, 2023, respectively

    181,590       183,093  

Additional paid-in capital

    65,637,265       67,732,887  

Accumulated other comprehensive loss

    (5,904

)

    -  

Accumulated deficit

    (20,078,137

)

    (22,042,427

)

Total stockholders equity

    45,742,491       45,881,931  

Total liabilities and stockholders equity

  $ 50,329,403     $ 50,583,431  

 

See accompanying notes to consolidated condensed financial statements.

 

 

- 1 -

 

 

REPOSITRAK, INC.

Consolidated Condensed Statements of Operations and Comprehensive Income (Unaudited)

 

   

Three Months Ended

December 31,

   

Six Months Ended

December 31,

 
   

2023

   

2022

   

2023

   

2022

 
                                 

Revenue

  $ 5,125,751     $ 4,750,513     $ 10,185,863     $ 9,470,990  
                                 

Operating expense:

                               

Cost of revenue and product support

    973,287       866,642       1,739,621       1,699,346  

Sales and marketing

    1,264,377       1,226,812       2,769,878       2,427,071  

General and administrative

    1,347,278       1,252,357       2,626,601       2,475,819  

Depreciation and amortization

    299,958       229,160       608,903       465,166  

Total operating expense

    3,884,900       3,574,971       7,745,003       7,067,402  
                                 

Income from operations

    1,240,851       1,175,542       2,440,860       2,403,588  
                                 

Other income (expense):

                               

Interest income

    316,445       199,266       574,606       278,358  

Interest expense

    (7,576

)

    (18,058

)

    (13,920

)

    (42,710

)

Unrealized gain (loss) on short term investments

    15,456       (31,406

)

    42,642       (38,821

)

Other gain

    -       -       -       70,047  

Income before income taxes

    1,565,176       1,325,344       3,044,188       2,670,462  
                                 

(Provision) for income taxes:

    (114,027

)

    (60,000

)

    (214,491

)

    (120,006

)

Net income

    1,451,149       1,265,344       2,829,697       2,550,456  
                                 

Dividends on preferred stock

    (146,611

)

    (146,611

)

    (293,222

)

    (293,222

)

                                 

Net income applicable to common shareholders

  $ 1,304,538     $ 1,118,733     $ 2,536,475     $ 2,257,234  
                                 

Weighted average shares, basic

    18,162,000       18,402,000       18,193,000       18,419,000  

Weighted average shares, diluted

    18,805,000       18,630,000       18,822,000       18,678,000  

Basic income per share

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  

Diluted income per share

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  
                                 
Comprehensive income:                                

Net income

  $ 1,451,149     $ 1,265,344     $ 2,829,697     $ 2,550,456  
Other comprehensive loss:                                

Unrealized loss on available-for-sale securities

    (5,904

)

    -       (5,904

)

    -  
                                 

Total comprehensive income

  $ 1,445,245     $ 1,265,344     $ 2,823,793     $ 2,550,456  

 

See accompanying notes to consolidated condensed financial statements.

 

- 2 -

 

 

REPOSITRAK, INC.

Consolidated Condensed Statements of Cash Flows (Unaudited)

 

   

Six Months

Ended December 31,

 
   

2023

   

2022

 

Cash flows from operating activities:

               

Net income

  $ 2,829,697     $ 2,550,456  

Adjustments to reconcile net income to net cash provided by operating activities:

               

Depreciation and amortization

    608,903       465,166  
Amortization of operating right-of-use asset     29,838       28,450  

Stock compensation expense

    171,373       209,869  

Bad debt expense

    150,000       300,000  

(Increase) decrease in:

               

Accounts receivables

    (1,389,753

)

    247,507  

Long-term receivables, prepaids and other assets

    127,755       21,431  

Increase (decrease) in:

               

Accounts payable

    (99,081

)

    (300,930

)

Operating lease liability

    (28,616

)

    (26,172

)

Accrued liabilities

    (71,733

)

    (207,025

)

Deferred revenue

    123,564       11,240  

Net cash provided by operating activities

    2,451,947       3,299,992  
                 

Cash flows from investing activities:

               

Purchase of property and equipment

    (10,523

)

    (270,854

)

Purchase of marketable securities

    (5,904

)

    -  

Net cash used in investing activities

    (16,427

)

    (270,854

)

                 

Cash flows from financing activities:

               
Net decrease in lines of credit     -       (2,142,165

)

Common Stock buyback/retirement

    (1,515,574

)

    (551,923

)

Redemption of series B-1 preferred

    (749,995

)

    -  

Proceeds from employee stock plan

    57,743       48,903  

Dividends paid

    (840,427

)

    (570,511

)

Payments on notes payable and capital leases

    (125,075

)

    125,865  

Net cash used in financing activities

    (3,173,328

)

    (3,089,831

)

                 

Net decrease in cash and cash equivalents

    (737,808

)

    (60,693

)

                 

Cash and cash equivalents at beginning of period

    23,990,879       21,460,948  

Cash and cash equivalents at end of period

  $ 23,253,071     $ 21,400,255  
                 

Supplemental disclosure of cash flow information:

               

Cash paid for income taxes

  $ 317,944     $ 264,486  

Cash paid for interest

  $ 6,434     $ 40,446  

Cash paid for operating leases

  $ 36,282     $ 35,226  
                 

Supplemental disclosure of non-cash investing and financing activities:

               

Common stock to pay accrued liabilities

  $ 110,000     $ 152,195  

Dividends accrued on preferred stock

  $ 293,222     $ 293,222  

 

See accompanying notes to consolidated condensed financial statements.

 

- 3 -

 

 

REPOSITRAK, INC.

Consolidated Condensed Statements of Stockholders Equity (Deficit) (Unaudited)

 

Six Months Ended December 31, 2023

 

   

Series B

Preferred Stock

   

Series B-1

Preferred Stock

   

Common Stock

   

Additional

Paid-In

   

Accumulated

    Accumulated Other Comprehensive          
   

Shares

   

Amount

   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

    Loss    

Total

 
                                                                                 

Balance, June 30, 2023

    625,375     $ 6,254       212,402     $ 2,124       18,309,051     $ 183,093     $ 67,732,887     $ (22,042,427 )     -     $ 45,881,931  

Stock issued for:

                                                                               

Accrued compensation

    -       -       -       -       3,716       37       37,463       -       -       37,500  

Employee stock plan

    -       -       -       -       13,326       133       57,610       -       -       57,743  

Stock buyback

    -       -       -       -       (155,025 )     (1,550 )     (1,320,532 )     -       -       (1,322,082 )
Preferred Dividends-Declared     -       -       -       -       -       -       -       (146,611 )     -       (146,611 )
Common Stock Dividends-Declared     -       -       -       -       -       -       -       (272,566 )     -       (272,566 )

Net income

    -       -       -       -       -       -       -       1,378,548       -       1,378,548  

Balance, September 30, 2023

    625,375     $ 6,254       212,402     $ 2,124       18,171,068     $ 181,713     $ 66,507,428     $ (21,083,056 )   $ -     $ 45,614,463  

Stock issued for:

                                                                               

Accrued compensation

    -       -       -       -       9,674       97       72,403       -       -       72,500  

Employee stock plan

    -       -       -       -       -       -       -       -       -       -  

Stock buyback

    -       -       -       -       (22,012 )     (220 )     (193,272 )     -       -       (193,492 )

Preferred stock redemption

    -       -       (70,093 )     (701 )     -       -       (749,294 )     -       -       (749,995 )
Preferred Dividends-Declared     -       -       -       -       -       -       -       (146,611 )     -       (146,611 )
Common Stock Dividends-Declare     -       -       -       -       -       -       -       (299,619 )     -       (299,619 )

Net income

    -       -       -       -       -       -       -       1,451,149       -       1,451,149  
Other comprehensive loss     -       -       -       -       -       -       -       -       (5,904 )     (5,904 )

Balance, December 31, 2023

    625,375     $ 6,254       142,309     $ 1,423       18,158,730     $ 181,590     $ 65,637,265     $ (20,078,137 )   $ (5,904 )   $ 45,742,491  

 

See accompanying notes to consolidated condensed financial statements.

 

- 4 -

 

Six Months Ended December 31, 2022

 

   

Series B

Preferred Stock

   

Series B-1

Preferred Stock

   

Common Stock

   

Additional

Paid-In

   

Accumulated

    Accumulated Other Comprehensive          
   

Shares

   

Amount

   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

    Loss    

Total

 
                                                                                 

Balance, June 30, 2022

    625,375     $ 6,254       212,402     $ 2,124       18,460,538     $ 184,608     $ 68,653,361     $ (25,943,287 )     -     $ 42,903,060  

Stock issued for:

                                                                    -          

Accrued compensation

    -       -       -       -       15,603       156       76,717       -       -       76,873  

Employee stock plan

    -       -       -       -       13,064       131       48,772       -       -       48,903  

Stock buyback

    -       -       -       -       (20,859 )     (209 )     (103,448 )     -       -       (103,657 )
Preferred Dividends-Declared     -       -       -       -       -       -       -       (146,611 )     -       (146,611 )
Common Stock Dividends-Declared     -       -       -       -       -       -       -       (277,162 )     -       (277,162 )

Net income

    -       -       -       -       -       -       -       1,285,112       -       1,285,112  
Balance, September 30, 2022     625,375     $ 6,254       212,402     $ 2,124       18,468,346     $ 184,686     $ 68,675,402     $ (25,081,948 )   $ -     $ 43,786,518  
                                                                                 

Stock issued for:

                                                                               

Accrued compensation

    -       -       -       -       14,691       147       75,175       -       -       75,322  

Stock buyback

    -       -       -       -       (88,741 )     (888 )     (447,378 )     -       -       (448,266 )
Preferred Dividends-Declared     -       -       -       -       -       -       -       (146,611 )     -       (146,611 )
Common Stock Dividends-Declared     -       -       -       -       -       -       -       (275,914 )     -       (275,914 )

Net income

    -       -       -       -       -       -       -       1,265,344       -       1,265,344  

Balance, December 31, 2022

    625,375       6,254       212,402       2,124       18,394,296       183,945       68,303,199       (24,239,129 )   $ -       44,256,393  

 

See accompanying notes to consolidated condensed financial statements.

 

- 5 -

 

 

REPOSITRAK, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1.

OVERVIEW OF OPERATIONS AND BASIS FOR PRESENTATION

 

Overview

 

ReposiTrak, Inc., a Nevada corporation (“ReposiTrak”, “We”, “us”, “our” or the “Company”) is a Software-as-a-Service (“SaaS”) which operates a business-to-business (“B2B”) e-commerce, compliance & traceability, and supply chain management platform that partners with retailers, wholesalers, distributors and their product suppliers to (a) help them manage specific programs, such as out-of-stock management and scan-based trading; (b) reduce risk in their supply chain by managing compliance documents and data; ensure compliance with new regulatory requirements supporting traceability; and (c) improve product ordering and forecasting in order to accelerate sales, control risks, and improve supply chain efficiencies.

 

The Company’s services are grouped in three application suites:

 

 

1.

ReposiTrak Compliance Management (“Compliance”) solutions, which helps the Company’s customers vet suppliers and reduce a company’s potential regulatory, legal, and criminal risk from its supply chain partners by providing a way for them to ensure these suppliers are compliant with food safety regulations, such as the Food Safety Modernization Act of 2011 (“FSMA”);

 

2.

ReposiTrak Traceability Network (“Traceability or RTN”), which helps the Company’s customers comply with federal regulatory requirements of traceability and provides the lowest cost, easiest to use way to manage the capture and sharing of key data elements (“KDEs”) now required by Section 204d of FSMA 2011 as designated products move through the supply chain at each ‘event’ known as a ‘critical tracking event’ or “CTE”, which includes tracking from farm to shelf; and

 

3.

ReposiTrak Supply Chain Solutions (“Supply Chain”), which help the Company’s customers to more efficiently manage various interactions with their suppliers. In other words, it provides customers with greater flexibility in sourcing products by enabling them to choose new suppliers and integrate them into their supply chain faster and more cost effectively, and it helps them to manage these relationships more efficiently, enhancing revenue while lowering working capital, labor costs and reducing waste.

 

The Company’s services are delivered though proprietary software products designed, developed, marketed, and supported by the Company. These products provide visibility and facilitate improved business processes among all key constituents in the supply chain, starting with the retailer and moving backwards to suppliers and eventually to raw material providers.

 

The Company provides cloud-based applications and services that address e-commerce, supply chain, food safety, compliance and traceability activities. The principal customers for the Company’s products are household name multi-store food retail chains and restaurants including their suppliers, branded food manufacturers, food wholesalers and distributors, and other food service businesses.

 

The Company has a hub and spoke business model. The Company is typically engaged by retailers and wholesalers (“Hubs”), which in turn require their suppliers (“Spokes”) to utilize the Company’s services.

 

On December 21, 2023, the Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc. The Company is incorporated in the State of Nevada and has two principal subsidiaries: PC Group, Inc., a Utah corporation (98.76% owned) (“PCG Utah”) and Park City Group, Inc., a Delaware corporation (100% owned) (“PCG Delaware” and together with PCG Utah, the “Subsidiaries”). All intercompany transactions and balances have been eliminated in the Company’s consolidated financial statements, which contain the operating results of the operations. The Company has no business operations separate from the operations conducted through its Subsidiaries.

 

The Company’s principal executive offices are located at 5282 South Commerce Drive, Suite D292, Murray, Utah 84107. Its telephone number is (435) 645-2000. Its website address is www.repositrak.com.

 

- 6 -

 

Basis of Financial Statement Presentation

 

The interim financial information of the Company as of December 31, 2023 and for the three and six months ended December 31, 2023 is unaudited, and the balance sheet as of June 30, 2023 is derived from audited financial statements. The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial statements. Accordingly, they omit or condense notes and certain other information normally included in financial statements prepared in accordance with U.S. GAAP. The accounting policies followed for quarterly financial reporting conform with the accounting policies disclosed in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended June 30, 2023. In the opinion of management, all adjustments necessary for a fair presentation of the financial information for the interim periods reported have been made. All such adjustments are of a normal recurring nature. The results of operations for the six months ended December 31, 2023 are not necessarily indicative of the results that can be expected for the fiscal year ending June 30, 2024. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended June 30, 2023.

 

NOTE 2.

SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation

 

The financial statements presented herein reflect the consolidated financial position of ReposiTrak, Inc. and our subsidiaries. All inter-company transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that materially affect the amounts reported in the consolidated financial statements. Actual results could differ from these estimates. The methods, estimates, and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results it reports in its financial statements. The U.S. Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as those that are most important to the portrayal of the Company’s financial condition and results and require the Company to make its most difficult and subjective judgments, often because of the need to make estimates of matters that are inherently uncertain. Based on this definition, the Company’s most critical accounting policies include revenue recognition, goodwill, other long-lived asset valuations, income taxes, stock-based compensation, and capitalization of software development costs.

 

Revenue Recognition

 

The Company recognizes revenue as it transfers control of deliverables (products, solutions and services) to its customers in an amount reflecting the consideration to which it expects to be entitled. To recognize revenue, the Company applies the following five step approach: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied. The Company accounts for a contract based on the terms and conditions the parties agree to, if the contract has commercial substance and if collectability of consideration is probable. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience.

 

The Company may enter into arrangements that consist of multiple performance obligations. Such arrangements may include any combination of its deliverables. To the extent a contract includes multiple promised deliverables, the Company applies judgment to determine whether promised deliverables are capable of being distinct and are distinct in the context of the contract. If these criteria are not met, the promised deliverables are accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, the Company allocates consideration among the performance obligations based on their relative standalone selling price. Standalone selling price is the price at which the Company would sell a promised good or service separately to the customer. When not directly observable, the Company typically estimates standalone selling price by using the expected cost plus a margin approach. The Company typically establishes a standalone selling price range for its deliverables, which is reassessed on a periodic basis or when facts and circumstances change.

 

For performance obligations where control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The selection of the method to measure progress towards completion requires judgment and is based on the nature of the deliverables to be provided. Revenue related to fixed-price contracts for application development and systems integration services, consulting or other technology services is recognized as the service is performed using the output method, under which the total value of revenue is recognized based on each contract’s deliverable(s) as they are completed and when value is transferred to a customer. Revenue related to fixed-price application maintenance, testing and business process services is recognized based on our right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in FASB ASC Topic 606, Revenue from Contracts with Customers (“Topic 606”), paragraph 606-10-55-18 (“ASC 606-10-55-18”).

 

- 7 -

 

If the Company’s invoicing is not consistent with the value delivered, revenue is recognized as the service is performed based on the method described above. The output method measures the results achieved and value transferred to a customer, which is updated as the project progresses to reflect the latest available information; such estimates and changes in estimates involve the use of judgment. The cumulative impact of any revision in estimates is reflected in the financial reporting period in which the change in estimate becomes known and any anticipated losses on contracts are recognized immediately. Revenue related to fixed-price hosting and infrastructure services is recognized based on the Company’s right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in ASC 606-10-55-18. If the Company’s invoicing is not consistent with value delivered, revenue is recognized on a straight-line basis unless revenue is earned and obligations are fulfilled in a different pattern. The revenue recognition method applied to the types of contracts described above provides the most faithful depiction of performance towards satisfaction of the Company’s performance obligations.

 

Revenue related to the Company’s software license arrangements that do not require significant modification or customization of the underlying software is recognized when the software is delivered as control is transferred at a point in time. For software license arrangements that require significant functionality enhancements or modification of the software, revenue for the software license and related services is recognized as the services are performed in accordance with the methods described above. In software hosting arrangements, the rights provided to the customer, such as ownership of a license, contract termination provisions and the feasibility of the client to operate the software, are considered in determining whether the arrangement includes a license or a service. Revenue related to software maintenance and support is generally recognized on a straight-line basis over the contract period.

 

Management expects that incremental commission fees paid as a result of obtaining a contract are recoverable and therefore the Company capitalized them as contract costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less.

 

Revenue related to transaction-based or volume-based contracts is recognized over the period the services are provided in a manner that corresponds with the value transferred to the customer to-date relative to the remaining services to be provided.

 

From time to time, the Company may enter into arrangements with third party suppliers to resell products or services. In such cases, the Company evaluates whether the Company is the principal (i.e., report revenue on a gross basis) or agent (i.e., report revenue on a net basis). In doing so, the Company first evaluates whether it controls the good or service before it is transferred to the customer. If the Company controls the good or service before it is transferred to the customer, the Company is the principal; if not, the Company is the agent. Determining whether the Company controls the good or service before it is transferred to the customer may require judgment.

 

The Company provides customers with assurance that the related deliverable will function as the parties intended because it complies with agreed-upon specifications. General updates or patch fixes are not considered an additional performance obligation in the contract.

 

Variable consideration is estimated using either the sum of probability weighted amounts in a range of possible consideration amounts (expected value), or the single most likely amount in a range of possible consideration amounts (most likely amount), depending on which method better predicts the amount of consideration to which we may be entitled. The Company includes in the transaction price variable consideration only to the extent it is probable that a significant reversal of revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company’s estimates of variable consideration and determination of whether to include estimated amounts in the transaction price may involve judgment and is based largely on an assessment of its anticipated performance and all information that is reasonably available to the Company.

 

The Company assesses the timing of the transfer of goods or services to the customer as compared to the timing of payments to determine whether a significant financing component exists. As a practical expedient, the Company does not assess the existence of a significant financing component when the difference between payment and transfer of deliverables is a year or less. If the difference in timing arises for reasons other than the provision of finance to either the customer or us, no financing component is deemed to exist. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing its services, not to receive or provide financing from or to customers. The Company does not consider set up or transition fees paid upfront by its customers to represent a financing component, as such fees are required to encourage customer commitment to the project and protect us from early termination of the contract.

 

- 8 -

 

Trade Accounts Receivable and Contract Balances

 

We classify our right to consideration in exchange for deliverables as either a receivable or a contract asset (unbilled receivable). A receivable is a right to consideration that is unconditional (i.e. only the passage of time is required before payment is due). For example, we recognize a receivable for revenue related to our transaction or volume-based contracts when earned regardless of whether amounts have been billed. We present such receivables in trade accounts receivable, net in our consolidated statements of financial position at their net estimated realizable value. We maintain an allowance for doubtful accounts to provide for the estimated amount of receivables that may not be collected. The allowance is based upon an assessment of customer creditworthiness, historical payment experience, the age of outstanding receivables, judgment, and other applicable factors.

 

A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented in current and other assets in our consolidated balance sheets and primarily relate to unbilled amounts on fixed-price contracts utilizing the output method of revenue recognition. The table below shows movements in contract assets:

 

   

Contract

assets

 

Balance – June 30, 2023

  $ 295,011  

Revenue recognized during the period but not billed

    -  

Amounts reclassified to accounts receivable

    (10,000

)

Other

    (26,779

)

Balance – December 31, 2023

  $ 258,232 (1)

 

 

(1)

Contract asset balances for December 31, 2023 include a current and a long-term contract asset of $150,180 and $108,052, respectively.

 

Our contract assets and liabilities are reported at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

The table below shows movements in the deferred revenue balances (current and noncurrent) for the period:

 

   

Contract

liability

 

Balance – June 30, 2023

  $ 1,903,001  

Amounts billed but not recognized as revenue

    885,218  

Revenue recognized related to the opening balance of deferred revenue

    (761,654

)

Balance – December 31, 2023

  $ 2,026,565  

 

Our contract assets and liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

Disaggregation of Revenue

 

The table below presents disaggregated revenue from contracts with customers by contract-type. We believe this disaggregation best depicts the nature, amount, timing and uncertainty of our revenue and cash flows that may be affected by industry, market, and other economic factors:

 

   

Three Months Ended

   

Six Months Ended

 
   

December 31,

   

December 31,

 
   

2023

   

2022

   

2023

   

2022

 
                                 
Recurring revenue – subscription and support services   $ 5,124,751     $ 4,743,216     $ 10,171,436     $ 9,421,193  

Non-recurring revenue – setup and training services

    1,000       7,297       14,427       49,797  
    $ 5,125,751     $ 4,750,513     $ 10,185,863     $ 9,470,990  

 

- 9 -

 

Earnings Per Share

 

Basic net income per share of Common Stock (“Basic EPS”) excludes dilution and is computed by dividing net income applicable to Common Stockholders by the weighted average number of Common Stock outstanding during the period. Diluted net income per share of Common Stock (“Diluted EPS”) reflects the potential dilution that could occur if stock options or other contracts to issue shares of Common Stock were exercised or converted into Common Stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an antidilutive effect on net income per share of Common Stock.

 

For the three and six months ended December 31, 2023 and 2022, warrants to purchase 23,737 shares of our common stock at an exercise price of $10.00 per share were anti-dilutive and not included in the computation of diluted earnings per share because the exercise price of the options was greater than the average price of common stock for the quarter.

 

The following table presents the components of the computation of basic and diluted earnings per share for the periods indicated:

 

   

Three Months Ended

   

Six Months Ended

 
   

December 31,

   

December 31,

 
   

2023

   

2022

   

2023

   

2022

 

Numerator

                               

Net income applicable to common shareholders

  $ 1,304,538     $ 1,118,733     $ 2,536,475     $ 2,257,234  
                                 

Denominator

                               

Weighted average common shares outstanding, basic

    18,162,000       18,402,000       18,193,000       18,419,000  

Warrants to purchase Common Stock

    643,000       228,000       629,000       259,000  

Weighted average common shares outstanding, diluted

    18,805,000       18,630,000       18,822,000       18,678,000  
                                 

Net income per share

                               

Basic

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  

Diluted

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform with the current year’s presentation. These reclassifications have no impact on the previously reported results.

 

NOTE 3.

EQUITY

 

Restricted Stock Units

 

Restricted

Stock Units

   

Weighted

Average
Grant Date
Fair Value

($/share)

 
                 

Outstanding at June 30, 2023

    907,451     $ 5.30  

Granted

    13,010       9.99  

Vested and issued

    (5,945

)

    5.89  

Forfeited

    -       -  

Outstanding at December 31, 2023

    914,516     $ 5.36  

 

As of December 31, 2023, there were 40,837 restricted stock units outstanding that had vested but for which shares of Common Stock had not yet been issued pursuant to the terms of the applicable agreement.

 

- 10 -

 

As of December 31, 2023, there was approximately $4.9 million of unrecognized stock-based compensation obligations under our equity compensation plans. The stock-based compensation obligation is in connection with certain employment agreements which have a deferral option at the Board’s discretion. At the end of the deferral period, the stock-based compensation expense associated with the obligation is expected to be recognized on a straight-line basis over a period of three years.

 

Warrants

 

Outstanding warrants were issued in connection with private placements of the Company’s Common Stock and with the restructuring of the Series B Preferred that occurred in March of 2018. The following table summarizes information about fixed stock warrants outstanding at December 31, 2023:

 

Warrants Outstanding

at December 31, 2023

   

Warrants Exercisable

at December 31, 2023

 

Range of

exercise

prices

   

Number

Outstanding

   

Weighted

average

remaining
contractual

life (years)

   

Weighted

average

exercise price

   

Number

exercisable

   

Weighted

average

exercise price

 
$ 4.00       1,085,068       2.10     $ 4.00       1,085,068     $ 4.00  
$ 10.00       23,737       2.07     $ 10.00       23,737     $ 10.00  
          1,108,805       2.10     $ 4.13       1,108,805     $ 4.13  

 

During the quarter ended March 31, 2023, the Company’s Board of Directors approved the modification to extend the expiration dates of the Company’s existing January 26, 2023 and February 5, 2023 warrants by an additional three years. Accordingly, all the Company’s outstanding warrants have been extended and are anticipated to expire or be exercised on or before the quarter ending March 31, 2026.

 

Preferred Stock

 

The Company’s articles of incorporation currently authorize the issuance of up to 30,000,000 shares of ‘blank check’ preferred stock, par value $0.01 (“Preferred Stock”), with designations, rights, and preferences as may be determined from time to time by the Company’s Board of Directors, of which 700,000 shares are currently designated as Series B Preferred Stock (“Series B Preferred”) and 550,000 shares are designated as Series B-1 Preferred Stock (“Series B-1 Preferred”). Both classes of Series B Preferred Stock pay dividends at a rate of 7% per annum if paid by the Company in cash, or 9% if paid by the Company by the issuance of additional shares of Series B-1 Preferred, or Series B-1 Preferred, as applicable.

 

Preferred Redemption

 

Section 4 of the Company’s First Amended and Restated Certificate of Designation of the Relative Rights, Powers and Preferences of the Series B-1 Preferred Stock, as amended (the “Series B-1 COD”) provides the Company’s Board of Directors with the right to redeem any or all of the outstanding shares of the Company’s Series B-1 Preferred for a cash payment of $10.70 per share at any time upon providing the holders of Series B-1 Preferred at least ten days written notice that sets forth the date on which the redemption will occur (the “Redemption Notice”).

 

On August 29, 2023, the Board approved the redemption and retirement of its Series B Preferred and Series B-1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”). The Preferred Redemption is to occur over the next three years from August 29, 2023.

 

As of December 31, 2023, a total of 625,375 shares of Series B Preferred and 142,309 shares of Series B-1 Preferred were issued and outstanding.

 

- 11 -

 

The following table provides information about the redemption of the Series B Preferred and Series B-1 Preferred during the six months ended December 31, 2023:

 

   

Series B Preferred and Series B-1 Preferred

 

Period (1)

 

Total
Number of
Shares
Redeemed

   

Price Paid
Per Share

   

Dollars

Expended

by Period

under the

Preferred

Redemption

   

Remaining
Amount
Available
for Future
Preferred Redemption

 

July 1, 2023 – September 30, 2023:

    -     $ 10.70     $ -     $ 8,964,214  

October 1, 2023 – December 31, 2023:

    70,093     $ 10.70     $ 749,995     $ 8,214,219  

Total

    70,093             $ 749,995     $ 8,214,219  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.

 

On August 29, 2023, the Board approved the redemption and retirement of its Series B Preferred and Series B-1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”). The Preferred Redemption is to occur over the next three years from August 29, 2023.

 

The following table provides information about the redemption and retirement of the Series B Preferred and Series B-1 Preferred during the three months ended December 31, 2023:

 

   

Series B Preferred

 

Period (1)

 

Total
Number of
Shares
Redeemed

   

Price Paid
Per Share

   

Dollars

Expended

by Period

under the

Preferred

Redemption

   

Remaining
Amount
Available
for Future
Preferred

Redemption

 

October 1, 2023 – December 31, 2023:

    -     $ 10.70     $ -     $ 6,691,513  

Total

    -             $ -     $ 6,691,513  

 

   

Series B-1 Preferred

 

Period (1)

 

Total
Number of
Shares
Redeemed

   

Price Paid
Per Share

   

Dollars

Expended

by Period

under the

Preferred

Redemption

   

Remaining
Amount
Available
for Future
Preferred

Redemption

 

October 1, 2023 – December 31, 2023:

    70,093     $ 10.70     $ 749,995     $ 1,522,706  

Total

    70,093             $ 749,995     $ 1,522,706  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.

 

Share Repurchase Program

 

On May 9, 2019, our Board of Directors approved the repurchase of up to $4.0 million in shares of our Common Stock, which repurchases may be made in privately negotiated transactions or in the open market at prices per share not exceeding the then-current market prices (the “Share Repurchase Program”). Under the Share Repurchase Program, management has discretion to determine the dollar amount of shares to be repurchased and the timing of any repurchases in compliance with applicable laws and regulations, including Rule 10b-18 of the Exchange Act.

 

On March 17, 2020, the Board, given the extreme uncertainty due to COVID-19 at the time, suspended the Share Repurchase Program.

 

On May 18, 2021, our Board of Directors resumed its Share Repurchase Program, and increased the number of shares of Common Stock available to repurchase under the Share Repurchase Program by an additional $4 million bringing the total number of Common Stock authorized to repurchase under the Share Repurchase Program to $8.0 million.

 

On August 31, 2021, our Board of Directors approved a further increase to its Share Repurchase program to $12.0 million in shares of our Common Stock which added an additional $4 million to the Share Repurchase Program.

 

- 12 -

 

On May 10, 2022, our Board of Directors approved an increase of $9.0 million in the number of shares of Common Stock available to repurchase under the Share Repurchase Program.

 

Since inception of the Share Repurchase Program through December 31, 2023, a total of $21,000,000 in shares of Common Stock have been approved under the Share Repurchase Program, and 2,122,703 shares of Common Stock have been repurchased at an average purchase price of $6.13, resulting in $7,992,206 remaining available to repurchase under the current Share Repurchase Program. From time-to-time, our Board of Directors may authorize further increases to our Share Repurchase Program. In addition, the Share Repurchase Program may also be suspended for periods of time or discontinued at any time, at the Board’s discretion.

 

The following table provides information about repurchases of our Common Stock registered pursuant to Section 12 of the Exchange Act, during the three months ended December 31, 2023:

 

Period (1)

 

Total
Number of
Shares
Purchased

   

Average
Price Paid
Per Share

   

Dollars

Expended

by Period

Under the

Plans or
Programs

   

Remaining
Amount
Available
for Future
Share
Repurchases
Under the
Plans or
Programs

 
July 1, 2023 – September 30, 2023     155,025     $ 8.53     $ 1,322,082     $ 8,185,698  

October 1, 2023 – December 31, 2023:

    22,012     $ 8.79     $ 193,492     $ 7,992,206  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.

 

NOTE 4.

RELATED PARTY TRANSACTIONS

 

During the six months ended December 31, 2023, the Company continued to be a party to a service agreement (the “Service Agreement”) with Fields Management, Inc. (“FMI”), pursuant to which FMI provided certain executive management services to the Company, including designating Randall K. Fields to perform the functions of President and Chief Executive Officer for the Company. Mr. Fields, FMI’s designated executive, who also serves as the Company’s Chair of the Board of Directors, controls FMI. The Company had no payables to FMI under the Service Agreement as of December, 2023 or 2022. During the six months ended December 31, 2023 and 2022, the Company paid FMI $484,902 and $462,030, respectively, in connection with the Service Agreement.

 

During the six months ended December 31, 2023, the Company, the Company redeemed and retired $749,995 in Series B-1 Preferred from Mr. Randall K. Fields, affiliates of Mr. Fields, and Robert W. Allen. Mr. Allen is a director of the Company.

 

NOTE 5.

RECENT ACCOUNTING PRONOUNCEMENTS

 

The Company has reviewed newly issued accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on its consolidated condensed financial statements as a result of future adoption.

 

NOTE 6.

SUBSEQUENT EVENTS

 

In accordance with the Subsequent Events Topic of the FASB ASC 855, we have evaluated subsequent events through the filing date and determined that no subsequent events occurred that were reasonably expected to impact the consolidated condensed financial statements presented herein.

 

- 13 -

 

 

 

ITEM 2.

MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q (this Report) contains forward-looking statements. The words or phrases would be, will allow, intends to, will likely result, are expected to, will continue, is anticipated, estimate, project, or similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties, including those risks factors contained in our June 30, 2023 Annual Report on Form 10-K, incorporated by reference herein. Statements made herein are as of the date of the filing of this Report with the Securities and Exchange Commission (SEC) and should not be relied upon as of any subsequent date. Unless otherwise required by applicable law, we do not undertake, and specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.

 

Overview

 

ReposiTrak, Inc., a Nevada corporation (“ReposiTrak”, “We”, “us”, “our” or the “Company”) is a Software-as-a-Service (“SaaS”) which operates a business-to-business (“B2B”) e-commerce, compliance & traceability, and supply chain management platform that partners with retailers, wholesalers, distributors and their product suppliers to (a) help them manage specific programs, such as out-of-stock management and scan-based trading; (b) reduce risk in their supply chain by managing compliance documents and data; ensure compliance with new regulatory requirements supporting traceability; and (c) improve product ordering and forecasting in order to accelerate sales, control risks, and improve supply chain efficiencies.

 

The Company’s services are grouped in three application suites:

 

 

1.

ReposiTrak Compliance Management (“Compliance”) solutions, which helps the Company’s customers vet suppliers and reduce a company’s potential regulatory, legal, and criminal risk from its supply chain partners by providing a way for them to ensure these suppliers are compliant with food safety regulations, such as the Food Safety Modernization Act of 2011 (“FSMA”);

 

2.

ReposiTrak Traceability Network (“Traceability or RTN”), which helps the Company’s customers comply with federal regulatory requirements of traceability and provides the lowest cost, easiest to use way to manage the capture and sharing of key data elements (KDEs) now required by Section 204d of FSMA 2011 as designated products move through the supply chain at each ‘event’ known as a ‘critical tracking event’ or “CTE”, which includes tracking from farm to shelf; and

 

3.

ReposiTrak Supply Chain Solutions (“Supply Chain”), which help the Company’s customers to more efficiently manage various interactions with their suppliers. In other words, it provides customers with greater flexibility in sourcing products by enabling them to choose new suppliers and integrate them into their supply chain faster and more cost effectively, and it helps them to manage these relationships more efficiently, enhancing revenue while lowering working capital, labor costs and reducing waste.

 

The Company’s services are delivered though proprietary software products designed, developed, marketed, and supported by the Company. These products provide visibility and facilitate improved business processes among all key constituents in the supply chain, starting with the retailer and moving backwards to suppliers and eventually to raw material providers.

 

The Company provides cloud-based applications and services that address e-commerce, supply chain, food safety, compliance, and traceability activities. The principal customers for the Company’s products are household name multi-store food retail chains and restaurants including their suppliers, branded food manufacturers, food wholesalers and distributors, and other food service businesses.

 

The Company has a hub and spoke business model. The Company is typically engaged by retailers and wholesalers (“Hubs”), which in turn require their suppliers (“Spokes”) to utilize the Company’s services.

 

On December 21, 2023, the Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc. The Company is incorporated in the State of Nevada and has two principal subsidiaries: PC Group, Inc., a Utah corporation (98.76% owned) (“PCG Utah”) and Park City Group, Inc., a Delaware corporation (100% owned) (“PCG Delaware” and together with PCG Utah, the “Subsidiaries”). All intercompany transactions and balances have been eliminated in the Company’s consolidated condensed financial statements, which contain the operating results of the operations. The Company has no business operations separate from the operations conducted through its Subsidiaries.

 

- 14 -

 

The Company’s principal executive offices are located at 5282 South Commerce Drive, Suite D292, Murray, Utah 84107. Its telephone number is (435) 645-2000. Its website address is www.repositrak.com. 

 

Recent Developments

 

Corporate Name Change

 

In connection with the rebranding of the Company, on December 21, 2023, the Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc., pursuant to a short-form merger with its wholly owned subsidiary, ReposiTrak, Inc., a Utah corporation, with the Company remaining as the surviving entity.

 

Dividend Payment

 

On December 12, 2023, the Company’s Board of Directors declared a quarterly cash dividend of $0.0165 per share ($0.066 per year), payable to shareholders of record on December 29, 2023, which were paid to shareholders of record on or about February 1, 2024. Based on the closing prices on December 31, 2023, this represented an annual dividend yield of approximately 0.65%. Subsequent quarterly dividends will be paid within 45 days of each record date of March 31, 2024, June 30, 2024, and September 30, 2024.

 

Redemption and Retirement of Preferred Stock

 

On August 29, 2023, the Board approved the redemption and retirement of its Series B Preferred and Series B-1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”).  The Preferred Redemption is to occur over the next three years from August 29, 2023.

 

As of December 31, 2023, a total of zero shares of Series B Preferred and 70,093 shares of Series B-1 Preferred were redeemed and retired, for aggregate consideration of $0 and $749,995 in the case of Series B Preferred and Series B-1 Preferred, respectively, resulting in a total of 625,375 shares of Series B Preferred and 142,309 shares of Series B-1 Preferred issued and outstanding at December 31, 2023.

 

Global Pandemics, Bank Failures, and Geopolitical Conflicts

 

The impact of global pandemics, including COVID 19, banking failures, geopolitical conflicts, including the war in Ukraine and tensions in the Middle East, creates much uncertainty in the global marketplace. Management continues to monitor the ongoing impact of these events on all aspects of its business, including how they impact its services, customers, employees, vendors, and business partners now and in the future. While these events did not materially adversely affect the Company’s financial results and business operations during the year ended June 30, 2023 or during the six months ended December 31, 2023, we are unable to predict the impact that these events, including geopolitical conflicts, will have on its future financial position and operating results due to numerous uncertainties.

 

Federal Regulation & Traceability: FSMA 204(d) and USDA SOE

 

In 2020, the United States Food & Drug Administration (“FDA”) announced the “New Era of Smarter Food Safety” blueprint. It “outlines achievable goals to enhance traceability, improve predictive analytics, respond more rapidly to outbreaks, address new business models, reduce contamination of food, and foster the development of stronger food safety cultures.”

 

In November, 2022, the FDA announced the final rule on the Food Safety Modernization Act Section 204(d) (“FSMA 204”) - Traceability for High-Risk Foods.

 

On January 20, 2023, the rule became effective and applies to any person or Company that manufactures, processes, packs or hold foods the FDA considers to be high risk for food borne illness, the so-called Food Traceability List (“FTL”). The FTL is comprised of 16 product categories of food, which represent thousands of products commonly sold in grocery and convenience stores, and all restaurants. As a result, every grocery distributor, wholesaler and retailer, and the food service supply chain, must now institute a traceability program that enables the capture, creation and sharing of specific Key Data Elements (“KDEs”) prescribed by the FDA and required for traceability, at each designated Critical Tracking Event (“CTE”) in the supply chain, for thousands of items.

 

FSMA 204 requires the traceability data records to be stored for two years, and be retrievable such that specific data records can be presented within 24 hours of a request from the FDA. FSMA 204 is ultimately about supply chain data recording record keeping, resulting is an enormous amount of data to manage, across more than one million supply chain and retail facilities.

 

The deadline for compliance with FSMA 204 is January 20, 2026, and nearly every company impacted will require some type of technical systems support to meet the requirement.

 

- 15 -

 

While the FTL includes thousands of product types, the FDA has made it clear in its communications that the list is only the beginning. The FDA states that it would “encourage the voluntary adoption of these practices industry-wide,” There are some strong early indications that the industry will move to complete traceability of all food products within the next few years.

 

In January of 2023, the United States Department of Agriculture (the “USDA”), which governs the National Organic Program, instituted new requirements under the Strengthening Organic Enforcement (“SOE”) rule. This rule will be enforced beginning in March 2024. The SOE is designed to reduce the amount of fraud in the organic products industry by increasing the requirements for facility certification and traceability of organic products. The timing and scope of the SOE traceability requirement will accelerate the adoption of traceability solutions across the entire food supply chain, much sooner than many anticipated.

 

In December 2023, one of the largest grocery retail chains in the US sent their suppliers a communication detailing their new traceability program requirements for ALL food products, not just the FDA required foods, with a deadline for compliance of June 2025, significantly earlier than the FDA FSMA 204 compliance deadline. It’s estimated that this new requirement could impact up to 20,000 food companies. If history is any indicator, we expect other large chains will follow the precedent set by this industry leader, resulting in effectively every supplier of food products sold in the United States will have the ability to simply and cost effectively share traceability data with their customers. 

 

Traceability is, by definition, a supply chain data management issue, which is ReposiTrak’s core expertise. That’s why we’ve made it our goal to develop a traceability solution that’s easy, inexpensive and exceeds FDA’s requirements. The ReposiTrak Traceability Network (“RTN”) is now the largest and fastest growing traceability solution, connecting thousands of supplier locations to thousands of food wholesaler and retail locations, using low cost, easy to deploy technology, on the ReposiTrak platform. As the largest connected network of food suppliers, wholesalers and retailers in the world, the ReposiTrak Traceability Network is well positioned to provide end-to-end traceability to provide a safer food supply chain, tighten controls on food waste, and implement a food recall response that saves lives and money.

 

Results of Operations

 

Comparison of the Three Months Ended December 31, 2023 to the Three Months Ended December 31, 2022.

 

Revenue

 

   

Fiscal Quarter Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Revenue

  $ 5,125,751     $ 4,750,513     $ 375,238       8

%

 

Revenue was $5,125,751 and $4,750,513 for the three months ended December 31, 2023 and 2022, respectively, a 8% increase year-over-year. The increase in revenue was due to revenue growth in subscription, services and other recurring revenue. This is the result of growing industry and consumer concern of food contaminations and food safety hazards, whether biological, chemical, physical, or allergenic. The risks have elevated regulatory requirements, documentation requisites, and principally “where does your food come from” transparency on grocery retailers and their suppliers.  As more and more retailers, wholesalers and distributors adopt the risk concerns and disclosure requirements, the Company has seen a corresponding rising demand for its services.

 

Although no assurances can be given, we continue to focus our sales efforts on marketing our software services on a recurring subscription basis and placing less emphasis on transactional revenue. However, we believe there will continue to be a small percentage of customers that will require buying a particular service outright (i.e., a license). We will continue to make our best effort to reduce this non-recurring transactional revenue when we are able.

 

Cost of Services and Product Support

 

   

Fiscal Quarter Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Cost of services and product support

  $ 973,287     $ 866,642     $ 106,645       12

%

Percent of total revenue

    19

%

    18

%

               

 

Cost of services and product support was $973,287 and $866,642 for the three months ended December 31, 2023 and 2022, respectively, a 12% increase. This $106,645 increase is primarily the result of increased developer headcount and support services in effort to support the acceleration and expansion of the FSMA 204 initiative. Given the demand in traceability, the Company expended additional resources on further upgrading its security and confidentiality protocols to increase protection of customer data.

 

Sales and Marketing Expense

 

   

Fiscal Quarter Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Sales and marketing

  $ 1,264,377     $ 1,226,812     $ 37,565       3

%

Percent of total revenue

    25

%

    26

%

               

 

- 16 -

 

Sales and marketing expense was $1,264,377 and $1,226,812 for the three months ended December 31, 2023 and 2022, respectively, a 3% increase. The increase in sales and marketing expense was primarily the result of an increase in trade show expense, investment in FSMA 204 traceability marketing, and higher sales travel expense. As the pandemic continues to abate, customers and prospects are returning to the “new normal” requiring in person meetings. The largest contributor to the increase in sales and marketing expense has been an increase in travel cost and trade shows. We believe this trend will continue as many of our trading partners and industry associations will continue to require our assistance in addressing their compliance and supply chain needs particularly in the case of the 2026 traceability deadline.

 

General and Administrative Expense

 

   

Fiscal Quarter Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

General and administrative

  $ 1,347,278     $ 1,252,357     $ 94,921       8

%

Percent of total revenue

    26

%

    26

%

               

 

General and administrative expense was $1,347,278 and $1,252,357 for the three months ended December 31, 2023 and 2022, respectively, an 8% increase. The increase in general and administrative expense was primarily due to increased salary expense and a rise in general operating costs caused by increased inflation and overall current market conditions. Those costs include but not limited to liability insurance, employee benefits, and other regulatory SOC compliance requirements.

 

Depreciation and Amortization Expense

 

   

Fiscal Quarter Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Depreciation and amortization

  $ 299,958     $ 229,160     $ 70,798       31

%

Percent of total revenue

    6

%

    5

%

               

 

Depreciation and amortization expense was $299,958 and $229,160 for the three months ended December 31, 2023 and 2022, respectively, an increase of 31%. The increase was due to additional assets acquired in the prior fiscal year. Given the rising global hacks on software companies, banks, and financial institutions, we spent approximately $420,000 on security, backup, storage, and redundancy. We believe this spending for hardware and software will continue for the foreseeable future as we continue to invest in our technology infrastructure, data warehousing and security initiatives. The upgrades were financed through a leasing agent with an effective APR rate of 4.45%.

 

Other Income and Expense

 

   

Fiscal Quarter Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Net other income (expense)

  $ 324,325     $ 149,802     $ 174,523       117

%

Percent of total revenue

    6

%

    3

%

               

 

Net other income was $324,325 for the three months ended December 31, 2023, compared to net other income of $149,802 for the three months ended December 31, 2022. Other income increased due to an increase in interest income attributable to elevated interest rates on fixed income instruments on excess cash.

 

Preferred Dividends

 

   

Fiscal Quarter Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Preferred dividends

  $ 146,611     $ 146,611     $ -       -

%

Percent of total revenue

    3

%

    3

%

               

 

Preferred dividends accrued on the Company’s Preferred Stock was $146,611 for the three months ended December 31, 2023 and for the three months ended December 31, 2022. Dividends remained flat in the comparable periods.

 

- 17 -

 

Comparison of the Six Months Ended December 31, 2023 to the Six Months Ended December 31, 2022.

 

Revenue

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Revenue

  $ 10,185,863     $ 9,470,990     $ 714,873       8

%

 

Revenue was $10,185,863 and $9,470,990 for the six months ended December 31, 2023 and 2022, respectively, an 8% increase year-over-year. The increase in revenue was due to revenue growth in subscription, services and other recurring revenue. This is the result of growing industry and consumer concern of food contaminations and food safety hazards, whether biological, chemical, physical, or allergenic. The risks have elevated regulatory requirements, documentation requisites, and principally “where does your food come from” transparency on grocery retailers and their suppliers.  As more and more retailers, wholesalers and distributors adopt the risk concerns and disclosure requirements, the Company has seen a corresponding rising demand for its services particularly in the case of traceability requirements in accordance with FSMA 204.

 

Although no assurances can be given, we continue to focus our sales efforts on marketing our software services on a recurring subscription basis and placing less emphasis on transactional revenue. However, we believe there will continue to be a small percentage of customers that will require buying a particular service outright (i.e., a license). We will continue to make our best effort to reduce this non-recurring transactional revenue when we are able.

 

Cost of Services and Product Support

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Cost of services and product support

  $ 1,739,621     $ 1,699,346     $ 40,275       2

%

Percent of total revenue

    17

%

    18

%

               

 

Cost of services and product support was $1,739,621 and $1,699,346 for the six months ended December 31, 2023 and 2022, respectively, a 2% increase. This $40,275 increase is primarily the result of increased developer headcount and support services in effort to support the acceleration and expansion of the FSMA 204 initiative. Given the demand in traceability the Company has expended additional resources on further upgrading its security and confidentiality to increase protection of customer data. 

 

Sales and Marketing Expense

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Sales and marketing

  $ 2,769,878     $ 2,427,071     $ 342,807       14

%

Percent of total revenue

    27

%

    26

%

               

 

Sales and marketing expense was $2,769,878 and $2,427,071 for the six months ended December 31, 2023 and 2022, respectively, a 14% increase. The increase in sales and marketing expense was primarily the result of an increase in trade show expense, investment in FSMA 204 traceability marketing, and higher sales travel expense. As the pandemic continues to abate, many customers and prospects are returning to the “new normal” requiring in person meetings. The largest contributor to the increase in sales and marketing expense has been an increase in travel cost and trade shows. We believe this trend will continue as many of our trading partners and industry associations will continue to require our assistance in addressing their compliance and supply chain needs.

 

General and Administrative Expense

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

General and administrative

  $ 2,626,601     $ 2,475,819     $ 150,782       6

%

Percent of total revenue

    26

%

    26

%

               

 

General and administrative expense was $2,626,601 and $2,475,819 for the six months ended December 31, 2023 and 2022, respectively, a 6% increase. The increase in general and administrative expense was primarily due to increased salary expense and a rise in general operating costs caused by increased inflation and overall current market conditions.

 

- 18 -

 

Depreciation and Amortization Expense

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Depreciation and amortization

  $ 608,903     $ 465,166     $ 143,737       31

%

Percent of total revenue

    6

%

    5

%

               

 

Depreciation and amortization expense was $608,903 and $465,166 for the six months ended December 31, 2023 and 2022, respectively, an increase of 31%. The increase was due to additional assets acquired in the prior fiscal year. Given the rising global hacks on software companies, banks, and financial institutions, we spent approximately $420,000 on security, backup, storage, and redundancy. The upgrades were financed through a leasing agent with an effective APR rate of 4.45%.

 

Other Income and Expense

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Net other income (expense)

  $ 603,328     $ 266,874     $ 336,454       126

%

Percent of total revenue

    6

%

    3

%

               

 

Net other income was $603,328 for the six months ended December 31, 2023, compared to net other income of $266,874 for the six months ended December 31, 2022. Other income increased due to an increase in interest income attributable to elevated interest rates on fixed income instruments on excess cash. When the Federal Reserve begins to cut rates in the future, it is unlikely the Company will be able to maintain the same interest income on its existing cash balances without taking additional credit risk.

 

Preferred Dividends

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Preferred dividends

  $ 293,222     $ 293,222     $ -       -

%

Percent of total revenue

    3     3

%

               

 

Dividends accrued on the Company’s Series B-1 Preferred was $293,222 for the six months ended December 31, 2023 and for the six months ended December 31, 2022. Dividends remained flat in the comparable periods.

 

Financial Position, Liquidity and Capital Resources

 

We believe that our existing cash and short-term investments, together with funds generated from operations, are sufficient to fund operating and investment requirements for at least the next twelve months. Our future capital requirements will depend on many factors, including macroeconomic conditions, our rate of revenue growth, sales and marketing activities, the timing and extent of spending required for research and development efforts and the continuing market acceptance of our products and services.

 

   

As of

   

Variance

 
   

December 31,

2023

   

June 30,

2023

   

Dollars

   

Percent

 

Cash and cash equivalents

  $ 23,253,071     $ 23,990,879     $ (737,808

)

    -3

%

 

We have historically funded our operations with cash from operations, equity financings, and borrowings from our existing line of credit with U.S. Bank N.A. (the “Bank”), which was revised on October 6, 2021, and again in 2022.

 

- 19 -

 

Cash was $23,253,071 and $23,990,879 at December 31, 2023 and June 30, 2023, respectively. This 3% decrease is primarily the result of the purchase of Common Stock under our Share Repurchase Program, the payment of dividends on both the Preferred Stock and Common Stock, and the redemption and retirement of shares of the Preferred Stock during the period.

 

Net Cash Flows from Operating Activities

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Cash provided by operating activities

  $ 2,451,947     $ 3,299,992     $ (848,045

)

    -26

%

 

Net cash provided by operating activities is summarized as follows:

 

   

Six Months Ended

December 31,

 
   

2023

   

2022

 

Net income

  $ 2,829,697     $ 2,550,456  

Noncash expense and income, net

    960,114       1,003,485  

Net changes in operating assets and liabilities

    (1,337,864

)

    (253,949

)

    $ 2,451,947     $ 3,299,992  

 

Net cash provided by operating activities for the six months ended December 31, 2023 was $2,451,947 as compared to net cash provided by operating activities of $3,299,992 for the six months ended December 31, 2022. Net cash provided by operating activities decreased 26% due principally to an increase in accounts receivable and a decrease in accounts payable. Noncash expense decreased by $43,371 in the six months ended December 31, 2023, compared to six months ended December 31, 2022 as a result of a decrease in bad debt expense and stock compensation expense offset by an increase in depreciation and amortization.

 

Net Cash Flows from Investing Activities

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Cash used in investing activities

  $ (16,427

)

  $ (270,854

)

  $ (254,427

)

    -94

%

 

Net cash used in investing activities for the six months ended December 31, 2023 was $16,427 compared to net cash used in investing activities of $270,854 for the six months ended December 31, 2022. This decrease in cash used in investing activities for the six months ended December 31, 2023 was due to purchases of property and equipment in the prior fiscal year during the six months ended December 31, 2022 that did not occur in the same period in 2023.

 

Net Cash Flows from Financing Activities

 

   

Six Months Ended

December 31,

   

Variance

 
   

2023

   

2022

   

Dollars

   

Percent

 

Cash used in financing activities

  $ (3,173,328

)

  $ (3,089,831

)

  $ 83,497       3

%

 

Net cash used in financing activities totaled $3,173,328 for the six months ended December 31, 2023, as compared to cash used in financing activities of $3,089,831 for the six months ended December 31, 2022. The increase in net cash used in financing activities is primarily attributable to the payment of Common Stock dividends, the purchase of Common Stock under the Share Repurchase Program, and the redemption and retirement of shares of Preferred Stock offset by decrease in cash payments due to the payoff of our line of credit arrangement with the Bank in the prior fiscal year.

 

- 20 -

 

Liquidity and Working Capital

 

At December 31, 2023, the Company had positive working capital of $23,298,163, as compared with positive working capital of $23,042,199 at June 30, 2023. This $255,964 increase in working capital is primarily due to an increase in accounts receivable and decrease in prepaid and other assets offset by a decrease in contract liabilities and an increase in deferred revenue. Cash and cash equivalents also decreased due to payment of quarterly Preferred Stock dividends, quarterly Common Stock dividend, buyback of Common Stock, and the redemption and retirement of Preferred Stock.

 

   

As of

December 31,

   

As of

June 30,

   

Variance

 
   

2023

   

2023

   

Dollars

   

Percent

 

Current assets

  $ 27,569,568     $ 27,274,620     $ 294,948       1

%

 

Current assets totaled $27,569,568 as of December 31, 2023, as compared to $27,274,620 as of June 30, 2023. The increase in current assets is primarily attributable to the decrease in cash, prepaid expense and other current assets offset by an increase in accounts receivables.

 

   

As of

December 31,

   

As of

June 30,

   

Variance

 
   

2023

   

2023

   

Change

   

Percent

 

Current liabilities

  $ 4,271,405     $ 4,232,421     $ 38,984       1

%

Current ratio

    6.45       6.44       0.01       -

%

 

Current liabilities totaled $4,271,405 as of December 31, 2023 as compared to $4,232,421 as of June 30, 2023. The increase in current liabilities is primarily attributable to the increase in deferred revenue offset by a decrease in accounts payable and financing lease liabilities. As of December 31, 2023, the Company has zero bank debt.

 

On October 6, 2021, the Company and U.S. Bank N.A. (the “Bank”) executed a Revolving Credit Agreement (the "Revolving Credit Agreement”) and accompanying addendum (the "Addendum"), and Stand-Alone Revolving Note (the "Note" and collectively with the Revolving Credit Agreement and Addendum, the "Credit Agreement"), with an effective date of September 30, 2021. The Credit Agreement replaced the Company’s prior $6.0 million Revolving Credit Agreement and Stand-Alone Revolving Note between the Company and the Bank, as amended and revised on January 9, 2019, and provided the Company with a $10.0 million revolving line of credit that matured on March 31, 2023. The Credit Agreement contained customary affirmative and negative covenants and conditions to borrowing, as well as customary events of default. Among other things, the Company must maintain liquid assets equal to $12 million and maintain a Senior Funded Debt (as defined in the Credit Agreement) to EBITDA Ratio (as defined in the Credit Agreement) of not more than 3:1.

 

On April 28, 2023, the Company and the Bank executed an amendment to the Credit Agreement (the “Amendment”), with an effective date of March 31, 2023. The Amendment to the Credit Agreement sets forth that (1) the Company will increase its liquidity requirement from $10 million to $12 million, which the Company currently maintains over $22 million in cash and a current ratio of over 6:1, and (2) draws on the facility accrue interest at the annual rate, equal to 1.75% plus the one-month SOFR rate, instead of the previous LIBOR rate. As of December 31, 2023, the balance of the facility was zero. The Company had zero bank debt at December 31, 2023.

 

While no assurances can be given, management currently believes that the Company will continue to increase its cash flow from operations and working capital position in subsequent periods. The Company’s increase in anticipated cash flow from operations and working capital position is expected to be offset by the use of cash required to fund the Company’s quarterly cash dividends of $0.015 per share, announced on September 28, 2022, December 30, 2022, February 10, 2023, March 21, 2023, June 20, 2023, September 19, 2023, and of $0.0165 per share, announced on December 12, 2023, as well as the  redemption and retirement of the Company’s Series B Convertible Preferred Stock and Series B-1 Preferred Stock (together, the “Preferred Stock”) for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”). 

 

The Preferred Redemption is to occur over the next three years from August 29, 2023.  As of December 31, 2023, a total of zero shares of Series B Preferred and 70,093 shares of Series B-1 Preferred were redeemed and retired, for aggregate consideration of $0 and $749,995 in the case of Series B Preferred and Series B-1 Preferred, respectively. The Company believes it will have adequate cash resources to fund its operations, satisfy its debt obligations, and fund its anticipated quarterly cash dividends and Preferred Redemption for at least the next 12 months.

 

- 21 -

 

Off-Balance Sheet Arrangements

 

The Company does not have any off-balance sheet arrangements that are reasonably likely to have a current or future effect on our financial condition, revenue, and results of operation, liquidity or capital expenditures.

 

Contractual Obligations

 

Total contractual obligations and commercial commitments as of December 31, 2023 are summarized in the following table:

 

   

Operating

Leases

   

Financing

Leases

 

Less than 1 Year

  $ 74,380     $ 224,200  

1-3 Years

    155,520       83,771  

3-5 Years

    94,889       -  

Total lease payments

    324,789       307,970  

Less imputed interest

    (31,587

)

    (7,751

)

Total

  $ 293,202     $ 300,219  

 

Critical Accounting Policies

 

This Management’s Discussion and Analysis of Financial Condition and Results of Operations discusses the Company’s financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles.

 

We commenced operations in the software development and professional services business during 1990. The preparation of our financial statements requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue and expense during the reporting period. On an ongoing basis, management evaluates its estimates and assumptions. Management bases its estimates and judgments on historical experience of operations and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

 

Management believes the following critical accounting policies, among others, will affect its more significant judgments and estimates used in the preparation of our consolidated financial statements.

 

Income Taxes

 

In determining the carrying value of the Company’s net deferred income tax assets, the Company must assess the likelihood of sufficient future taxable income in certain tax jurisdictions, based on estimates and assumptions, to realize the benefit of these assets. If these estimates and assumptions change in the future, the Company may record a reduction in the valuation allowance, resulting in an income tax benefit in the Company’s statements of operations. Management evaluates whether to realize the deferred income tax assets and assesses the valuation allowance quarterly.

 

Goodwill and Other Long-Lived Asset Valuations

 

Goodwill and other long-lived assets assigned to specific reporting units are reviewed for possible impairment at least annually or more frequently upon the occurrence of an event or when circumstances indicate that a reporting unit’s carrying amount is greater than its fair value. Management reviews the long-lived tangible and intangible assets for impairment when events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. Management evaluates, at each balance sheet date, whether events and circumstances have occurred which indicate possible impairment. The carrying value of a long-lived asset is considered impaired when the anticipated cumulative undiscounted cash flows of the related asset or group of assets is less than the carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the estimated fair market value of the long-lived asset. Economic useful lives of long-lived assets are assessed and adjusted as circumstances dictate.

 

- 22 -

 

Revenue Recognition 

 

Effective July 1, 2018, the Company adopted the Financial Accounting Standards Board’s Accounting Standards Update 2014-09: Revenue from Contracts with Customers (Topic 606), and its related amendments (“ASU 2014-09”). ASU 2014-09 provides a unified model to determine when and how revenue is recognized and enhances certain disclosure around the nature, timing, amount and uncertainty of revenue and cash flows arising from customers.

 

ASU 2014-09 represents a change in the accounting model utilized for the recognition of revenue and certain expense arising from contracts with customers. The Company adopted ASU 2014-09 using a “modified retrospective” approach and, accordingly, revenue and expense totals for all periods before July 1, 2018 reflect those previously reported under the prior accounting model and have not been restated.

 

See Note 2 to our Unaudited Consolidated Financial Statements included in Part I, Item 1 of this Report for a full description of the impact of the adoption of new accounting standards on our financial statements. Following the adoption of this guidance, the revenue recognition for our sales arrangements remained materially consistent with our historical practice and there have been no material changes to our critical accounting policies and estimates as compared to our critical accounting policies and estimates included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023.

 

Share-Based Compensation

 

The Company accounts for its share-based compensation to employees and non-employees in accordance with FASB ASC 718, Compensation Stock Compensation. Stock-based compensation cost is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service or vesting period.

 

Leases

 

Effective July 1, 2019, the Company adopted the requirements of Accounting Standards Update No. 2016-02, "Leases (Topic 842)" ("ASU 2016-02"). All amounts and disclosures set forth in this Report have been updated to comply with this new standard with results for reporting periods beginning after July 1, 2019 presented under ASU 2016-02, while prior period amounts and disclosures are not adjusted and continue to be reported under the accounting standards in effect for the prior period.

 

Available-for-Sale Debt Investments

 

We classify our investments in fixed income securities as available-for-sale debt investments. Our available-for-sale debt investments primarily consist of U.S. government, U.S. government agency, non-U.S. government and agency, corporate debt, U.S. agency mortgage-backed securities, commercial paper and certificates of deposit. These available-for-sale debt investments are primarily held in the custody of a major financial institution. A specific identification method is used to determine the cost basis of available-for-sale debt investments sold. These investments are recorded in the Consolidated Balance Sheets at fair value. Unrealized gains and losses on these investments are included as a separate component of accumulated other comprehensive income (“AOCI”). We classify our investments as current based on the nature of the investments and their availability for use in current operations.

 

Impairment Consideration of Investments  

 

For our available-for-sale debt securities in an unrealized loss position, we determine whether a temporary or permanent credit loss exists. In this assessment, which requires judgment, among other factors, we consider the extent to which the fair value is less than the amortized cost, any changes to the rating of the security by a rating agency, and adverse conditions specifically related to the security. If factors indicate a permanent credit loss exists, an allowance for credit loss is recorded to other income (loss), net, limited by the amount that the fair value is less than the amortized cost basis. The amount of fair value change relating to all other factors will be recognized in other comprehensive income (“OCI”).

 

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Our business is conducted principally in the United States. As a result, our financial results are not affected by factors such as changes in foreign currency exchange rates or economic conditions in foreign markets. We do not engage in hedging transactions to reduce our exposure to changes in currency exchange rates, although if the geographical scope of our business broadens, we may do so in the future.

 

Our exposure to risk for changes in interest rates relates primarily to our investments in short-term financial instruments. Investments in both fixed rate and floating rate interest earning instruments carry some interest rate risk. The fair value of fixed rate securities may fall due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Partly as a result of this, our future interest income may fall short of expectations due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that have fallen in estimated fair value due to changes in interest rates. However, as substantially all of our cash consist of bank deposits and short-term money market instruments, we do not expect any material change with respect to our net income as a result of an interest rate change. 

 

Our exposure to interest rate changes related to borrowing has been limited, and we believe the effect, if any, of near-term changes in interest rates on our financial position, results of operations and cash flows should not be material. At December 31, 2023, our debt portfolio was composed of (1) Bank Line of Credit – SOFR + 1.75%.  The balance is zero.  (2) Leases – Effective APR Fixed is 4.55%. Total lease obligations are on a three-year straight-line basis.  The total cost is less than $400,000.

 

The table that follows presents fair values of principal amounts and weighted average interest rates for our investment portfolio as of December 31, 2023:

 

Cash:

 

Aggregate

Fair Value

   

Weighted

Average

Interest Rate

 

Cash

  $ 23,253,071       5.05

%

 

- 23 -

 

ITEM 4.

CONTROLS AND PROCEDURES

 

(a)

Evaluation of disclosure controls and procedures. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, an evaluation of the effectiveness of the design and operations of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of December 31, 2023 was completed. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer believe that our disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms, including to ensure that information required to be disclosed by the Company is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

(b)

Changes in internal controls over financial reporting. The Company’s Chief Executive Officer and Chief Financial Officer have determined that there have been no changes in the Company’s internal control over financial reporting during the period covered by this report identified in connection with the evaluation described in the above paragraph that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II

 

OTHER INFORMATION

 

ITEM 1.

LEGAL PROCEEDINGS

 

We are, from time-to-time, involved in various legal proceedings incidental to the conduct of our business. Historically, the outcome of all such legal proceedings has not, in the aggregate, had a material adverse effect on our business, financial condition, results of operations or liquidity. There is currently no pending or threatened material legal proceeding that, in the opinion of management, could have a material adverse effect on our business or financial condition.

 

ITEM 1A.

RISK FACTORS

 

There are no risk factors identified by the Company in addition to the risk factors previously disclosed in Part I, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended June 30, 2023.

 

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None.

 

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

 

None.

 

 

ITEM 5.

OTHER INFORMATION

 

None.

 

 

ITEM 6.

EXHIBITS

 

31.1

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document

101.SCH

Inline XBRL Taxonomy Extension Schema

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase

104

Cover Page Interactive Data File - formatted in Inline XBRL (included as Exhibit 101)

 

- 24 -

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

REPOSITRAK, INC. 

       

Date:  February 14, 2024

By:  

/s/ Randall K. Fields

 
   

Randall K. Fields 

 
   

Chair of the Board and Chief Executive Officer

(Principal Executive Officer)

 

 

 

REPOSITRAK, INC. 

       

Date: February 14, 2024

By:  

/s/ John R. Merrill

 
   

John R. Merrill

 
   

Chief Financial Officer

(Principal Financial Officer & Principal Accounting Officer)

 

 

 

- 25 -

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13A-14(A)

 

I, Randall K. Fields, certify that:

 

1.  I have reviewed this quarterly report on Form 10-Q of ReposiTrak, Inc.;

 

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and 

 

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 14, 2024

By:

/s/ Randall K. Fields

   

Randall K. Fields

Chief Executive Officer and Chair of the Board

(Principal Executive Officer)

 

 

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULE 13A-14(A)

 

I, John R. Merrill, certify that:

 

1.  I have reviewed this quarterly report on Form 10-Q of ReposiTrak, Inc.;

 

2.  Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.  Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.  The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financing reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. 

 

Date: February 14, 2024

By:

/s/ John R. Merrill

   

John R. Merrill

Chief Financial Officer

(Principal Financial Officer & Principal Accounting Officer)

 

 

 

Exhibit 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. Sec.1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the accompanying Quarterly Report of ReposiTrak, Inc. (the “Company”) on Form 10-Q for the period ending December 31, 2023 as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), the undersigned, Randall K. Fields, Principal Executive Officer of the Company, certifies, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

Date: February 14, 2024

By:

/s/ Randall K. Fields

   

Randall K. Fields

Chief Executive Officer and Chair of the Board

(Principal Executive Officer)

 

 

 

Exhibit 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. Sec.1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the accompanying Quarterly Report of ReposiTrak, Inc. (the “Company”) on Form 10-Q for the period ending December 31, 2023 as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), the undersigned, John R. Merrill, Principal Financial Officer of the Company, certifies, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

Date: February 14, 2024

By:

/s/ John R. Merrill

   

John R. Merrill

Chief Financial Officer

(Principal Financial Officer & Principal Accounting Officer)

 

 

 
v3.24.0.1
Document And Entity Information - shares
3 Months Ended
Dec. 31, 2023
Feb. 14, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2023  
Document Transition Report false  
Entity File Number 001-34941  
Entity Registrant Name REPOSITRAK, INC.  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 37-1454128  
Entity Address, Address Line One 5282 South Commerce Drive, Suite D292  
Entity Address, City or Town Murray  
Entity Address, State or Province UT  
Entity Address, Postal Zip Code 84107  
City Area Code 435  
Local Phone Number 645-2000  
Title of 12(b) Security Common stock, par value $0.01 per share  
Trading Symbol TRAK  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   18,209,501
Entity Central Index Key 0000050471  
Current Fiscal Year End Date --06-30  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q2  
Amendment Flag false  
v3.24.0.1
Consolidated Condensed Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2023
Jun. 30, 2023
Current Assets    
Cash and cash equivalents $ 23,253,071 $ 23,990,879
Receivables, net of allowance for doubtful accounts of $219,163 and $170,103 at December 31, 2023 and June 30, 2023, respectively 3,799,551 2,523,019
Contract asset – unbilled current portion 150,180 186,959
Prepaid expense and other current assets 366,766 573,763
Total Current Assets 27,569,568 27,274,620
Property and equipment, net 716,979 986,300
Other Assets:    
Deposits and other assets 22,414 22,414
Prepaid expense – less current portion 8,996 36,282
Contract asset – unbilled long-term portion 108,052 108,052
Operating lease – right-of-use asset 280,958 310,796
Goodwill 20,883,886 20,883,886
Capitalized software costs, net 541,450 698,281
Total Other Assets 22,042,856 22,322,511
Total Assets 50,329,403 50,583,431
Current liabilities    
Accounts payable 332,306 431,387
Accrued liabilities 1,634,620 1,620,000
Contract liability – deferred revenue 2,026,565 1,903,001
Operating lease liability – current 61,372 58,771
Notes payable and financing leases – current 216,542 219,262
Total current liabilities 4,271,405 4,232,421
Long-term liabilities    
Operating lease liability – less current portion 231,830 263,047
Notes payable and financing leases – less current portion 83,677 206,032
Total liabilities 4,586,912 4,701,500
Commitments and Contingencies  
Stockholders’ equity:    
Common Stock, $0.01 par value, 50,000,000 shares authorized; 18,158,730 and 18,309,051 issued and outstanding at December 31, 2023 and June 30, 2023, respectively 181,590 183,093
Additional paid-in capital 65,637,265 67,732,887
Accumulated other comprehensive loss (5,904) 0
Accumulated deficit (20,078,137) (22,042,427)
Total stockholders’ equity 45,742,491 45,881,931
Total liabilities and stockholders’ equity 50,329,403 50,583,431
Series B Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock 6,254 6,254
Series B-1 Preferred Stock [Member]    
Stockholders’ equity:    
Preferred stock 1,423 2,124
Customer Relationships [Member]    
Other Assets:    
Customer relationships $ 197,100 $ 262,800
v3.24.0.1
Consolidated Condensed Balance Sheets (Unaudited) (Parentheticals) - USD ($)
Dec. 31, 2023
Jun. 30, 2023
Accounts Receivable, Allowance for Credit Loss, Current $ 219,163 $ 170,103
Preferred Stock, Par or Stated Value Per Share (in dollars per share) $ 0.01 $ 0.01
Preferred Stock, Shares Authorized (in shares) 30,000,000 30,000,000
Preferred Stock, Shares Authorized (in shares) 30,000,000 30,000,000
Common Stock, Par or Stated Value Per Share (in dollars per share) $ 0.01 $ 0.01
Common Stock, Shares Authorized (in shares) 50,000,000 50,000,000
Common Stock, Shares, Issued (in shares) 18,158,730 18,309,051
Common Stock, Shares, Outstanding, Ending Balance (in shares) 18,158,730 18,309,051
Series B Preferred Stock [Member]    
Preferred Stock, Shares Authorized (in shares) 700,000 700,000
Preferred Stock, Shares Authorized (in shares) 700,000 700,000
Preferred Stock, Shares Outstanding (in shares) 625,375 625,375
Preferred Stock, Shares Issued (in shares) 625,375 625,375
Series B-1 Preferred Stock [Member]    
Preferred Stock, Shares Authorized (in shares) 550,000 550,000
Preferred Stock, Shares Authorized (in shares) 550,000 550,000
Preferred Stock, Shares Outstanding (in shares) 142,309 212,402
Preferred Stock, Shares Issued (in shares) 142,309 212,402
v3.24.0.1
Consolidated Condensed Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Revenue $ 5,125,751 $ 4,750,513 $ 10,185,863 $ 9,470,990
Operating expense:        
Cost of revenue and product support 973,287 866,642 1,739,621 1,699,346
Sales and marketing 1,264,377 1,226,812 2,769,878 2,427,071
General and administrative 1,347,278 1,252,357 2,626,601 2,475,819
Depreciation and amortization 299,958 229,160 608,903 465,166
Total operating expense 3,884,900 3,574,971 7,745,003 7,067,402
Income from operations 1,240,851 1,175,542 2,440,860 2,403,588
Other income (expense):        
Interest income 316,445 199,266 574,606 278,358
Interest expense (7,576) (18,058) (13,920) (42,710)
Unrealized gain (loss) on short term investments 15,456 (31,406) 42,642 (38,821)
Other gain (loss) 0 0 0 70,047
Income before income taxes 1,565,176 1,325,344 3,044,188 2,670,462
(Provision) for income taxes: (114,027) (60,000) (214,491) (120,006)
Net income 1,451,149 1,265,344 2,829,697 2,550,456
Dividends on preferred stock (146,611) (146,611) (293,222) (293,222)
Net income applicable to common shareholders $ 1,304,538 $ 1,118,733 $ 2,536,475 $ 2,257,234
Weighted average shares, basic (in shares) 18,162,000 18,402,000 18,193,000 18,419,000
Weighted average shares, diluted (in shares) 18,805,000 18,630,000 18,822,000 18,678,000
Basic income per share (in dollars per share) $ 0.07 $ 0.06 $ 0.14 $ 0.12
Diluted income per share (in dollars per share) $ 0.07 $ 0.06 $ 0.14 $ 0.12
Other comprehensive income (loss) Net income $ 1,451,149 $ 1,265,344 $ 2,829,697 $ 2,550,456
Unrealized loss on available-for-sale securities (5,904) 0 (5,904) 0
Total comprehensive income (loss) $ 1,445,245 $ 1,265,344 $ 2,823,793 $ 2,550,456
v3.24.0.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Other comprehensive income (loss) Net income $ 2,829,697 $ 2,550,456
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 608,903 465,166
Amortization of operating right of use asset 29,838 28,450
Stock compensation expense 171,373 209,869
Bad debt expense 150,000 300,000
(Increase) decrease in:    
Accounts receivables (1,389,753) 247,507
Long-term receivables, prepaids and other assets 127,755 21,431
Accounts payable (99,081) (300,930)
Operating lease liability (28,616) (26,172)
Accrued liabilities (71,733) (207,025)
Deferred revenue 123,564 11,240
Net cash provided by operating activities 2,451,947 3,299,992
Cash flows from investing activities:    
Purchase of property and equipment (10,523) (270,854)
Purchase of marketable securities 5,904 (0)
Net cash provided by (used in) investing activities (16,427) (270,854)
Cash flows from financing activities:    
Net (decrease) increase in lines of credit 0 (2,142,165)
Common stock buy-back/retirement (1,515,574) (551,923)
Redemption of series B-1 preferred (749,995) 0
Proceeds from employee stock plan 57,743 48,903
Dividends paid (840,427) (570,511)
Payments on notes payable and capital leases (125,075) 125,865
Net cash used in financing activities (3,173,328) (3,089,831)
Net increase (decrease) in cash and cash equivalents (737,808) (60,693)
Cash and cash equivalents at beginning of period 23,990,879 21,460,948
Cash and cash equivalents at end of period 23,253,071 21,400,255
Supplemental Disclosure of Cash Flow Information    
Cash paid for income taxes 317,944 264,486
Cash paid for interest 6,434 40,446
Cash paid for operating leases 36,282 35,226
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Dividends accrued on preferred stock 293,222 293,222
Common Stock to Pay Accrued Liabilities [Member]    
Supplemental Disclosure of Non-Cash Investing and Financing Activities    
Common stock to pay accrued liabilities $ 110,000 $ 152,195
v3.24.0.1
Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series B-1 Preferred Stock [Member]
Preferred Stock [Member]
Series B-1 Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Jun. 30, 2022 625,375 212,402   18,460,538        
Balance at Jun. 30, 2022 $ 6,254 $ 2,124   $ 184,608 $ 68,653,361 $ (25,943,287) $ 0 $ 42,903,060
Accrued compensation (in shares)       15,603     0  
Accrued compensation       $ 156 76,717 0   76,873
Employee stock plan (in shares)       13,064        
Employee stock plan       $ 131 48,772 0 $ 0 48,903
Stock buyback (in shares)       (20,859)        
Stock buyback       $ (209) (103,448) 0 0 (103,657)
Preferred Dividends-Declared       0 0 (146,611) 0 (146,611)
Common Stock Dividends-Declared       0 0 (277,162) 0 (277,162)
Other comprehensive income (loss) Net income       $ 0 0 1,285,112 0 1,285,112
Balance (in shares) at Sep. 30, 2022 625,375 212,402   18,468,346        
Balance at Sep. 30, 2022 $ 6,254 $ 2,124   $ 184,686 68,675,402 (25,081,948) 0 43,786,518
Balance (in shares) at Jun. 30, 2022 625,375 212,402   18,460,538        
Balance at Jun. 30, 2022 $ 6,254 $ 2,124   $ 184,608 68,653,361 (25,943,287) 0 42,903,060
Other comprehensive income (loss) Net income               2,550,456
Balance (in shares) at Dec. 31, 2022 625,375 212,402   18,394,296        
Balance at Dec. 31, 2022 $ 6,254 $ 2,124   $ 183,945 68,303,199 (24,239,129) 0 44,256,393
Balance (in shares) at Sep. 30, 2022 625,375 212,402   18,468,346        
Balance at Sep. 30, 2022 $ 6,254 $ 2,124   $ 184,686 68,675,402 (25,081,948) $ 0 43,786,518
Accrued compensation (in shares) 0 0   14,691     0  
Accrued compensation $ 0 $ 0   $ 147 75,175 0   75,322
Stock buyback (in shares) 0 0   (88,741)        
Stock buyback $ 0 $ 0   $ (888) (447,378) 0 $ 0 (448,266)
Preferred Dividends-Declared 0 0   0 0 (146,611) 0 (146,611)
Common Stock Dividends-Declared       0 0 (275,914) 0 (275,914)
Other comprehensive income (loss) Net income $ 0 $ 0   $ 0 0 1,265,344 0 1,265,344
Balance (in shares) at Dec. 31, 2022 625,375 212,402   18,394,296        
Balance at Dec. 31, 2022 $ 6,254 $ 2,124   $ 183,945 68,303,199 (24,239,129) 0 44,256,393
Balance (in shares) at Jun. 30, 2023 625,375 212,402   18,309,051        
Balance at Jun. 30, 2023 $ 6,254 $ 2,124   $ 183,093 67,732,887 (22,042,427) 0 45,881,931
Accrued compensation (in shares)       3,716        
Accrued compensation       $ 37 37,463 0 0 37,500
Employee stock plan (in shares)       13,326        
Employee stock plan       $ 133 57,610 0 0 $ 57,743
Stock buyback (in shares)       (155,025)       (155,025)
Stock buyback       $ (1,550) (1,320,532) 0 0 $ (1,322,082)
Preferred Dividends-Declared       0 0 (146,611) 0 (146,611)
Common Stock Dividends-Declared       0 0 (272,566) 0 (272,566)
Other comprehensive income (loss) Net income       $ 0 0 1,378,548 0 1,378,548
Balance (in shares) at Sep. 30, 2023 625,375 212,402   18,171,068        
Balance at Sep. 30, 2023 $ 6,254 $ 2,124   $ 181,713 66,507,428 (21,083,056) 0 45,614,463
Balance (in shares) at Jun. 30, 2023 625,375 212,402   18,309,051        
Balance at Jun. 30, 2023 $ 6,254 $ 2,124   $ 183,093 67,732,887 (22,042,427) 0 45,881,931
Other comprehensive income (loss) Net income               $ 2,829,697
Preferred stock redemption (in shares)               (70,093)
Balance (in shares) at Dec. 31, 2023 625,375 142,309   18,158,730        
Balance at Dec. 31, 2023 $ 6,254 $ 1,423   $ 181,590 65,637,265 (20,078,137) (5,904) $ 45,742,491
Balance (in shares) at Sep. 30, 2023 625,375 212,402   18,171,068        
Balance at Sep. 30, 2023 $ 6,254 $ 2,124   $ 181,713 66,507,428 (21,083,056) 0 45,614,463
Accrued compensation (in shares) 0 0   9,674        
Accrued compensation $ 0 $ 0   $ 97 72,403 0 0 72,500
Employee stock plan (in shares) 0 0   0        
Employee stock plan $ 0 $ 0   $ 0 0 0 0 $ 0
Stock buyback (in shares) 0 0   (22,012)       (22,012) [1]
Stock buyback $ 0 $ 0   $ (220) (193,272) 0 0 $ (193,492)
Preferred Dividends-Declared 0 0   0 0 (146,611) 0 (146,611)
Common Stock Dividends-Declared       0 0 (299,619) 0 (299,619)
Other comprehensive income (loss) Net income $ 0 $ 0   $ 0 0 1,451,149 0 1,451,149
Preferred stock redemption (in shares)   (70,093) (70,093) [2]          
Preferred stock redemption   $ (701) $ (749,995)   (749,294) 0 0 (749,995)
Other comprehensive income (loss)           0 (5,904) (5,904)
Balance (in shares) at Dec. 31, 2023 625,375 142,309   18,158,730        
Balance at Dec. 31, 2023 $ 6,254 $ 1,423   $ 181,590 $ 65,637,265 $ (20,078,137) $ (5,904) $ 45,742,491
[1] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
[2] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
v3.24.0.1
Note 1 - Overview of Operations and Basis for Presentation
3 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Business Description and Basis of Presentation [Text Block]

REPOSITRAK, INC.

NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

NOTE 1.

OVERVIEW OF OPERATIONS AND BASIS FOR PRESENTATION

 

Overview

 

ReposiTrak, Inc., a Nevada corporation (“ReposiTrak”, “We”, “us”, “our” or the “Company”) is a Software-as-a-Service (“SaaS”) which operates a business-to-business (“B2B”) e-commerce, compliance & traceability, and supply chain management platform that partners with retailers, wholesalers, distributors and their product suppliers to (a) help them manage specific programs, such as out-of-stock management and scan-based trading; (b) reduce risk in their supply chain by managing compliance documents and data; ensure compliance with new regulatory requirements supporting traceability; and (c) improve product ordering and forecasting in order to accelerate sales, control risks, and improve supply chain efficiencies.

 

The Company’s services are grouped in three application suites:

 

 

1.

ReposiTrak Compliance Management (“Compliance”) solutions, which helps the Company’s customers vet suppliers and reduce a company’s potential regulatory, legal, and criminal risk from its supply chain partners by providing a way for them to ensure these suppliers are compliant with food safety regulations, such as the Food Safety Modernization Act of 2011 (“FSMA”);

 

2.

ReposiTrak Traceability Network (“Traceability or RTN”), which helps the Company’s customers comply with federal regulatory requirements of traceability and provides the lowest cost, easiest to use way to manage the capture and sharing of key data elements (“KDEs”) now required by Section 204d of FSMA 2011 as designated products move through the supply chain at each ‘event’ known as a ‘critical tracking event’ or “CTE”, which includes tracking from farm to shelf; and

 

3.

ReposiTrak Supply Chain Solutions (“Supply Chain”), which help the Company’s customers to more efficiently manage various interactions with their suppliers. In other words, it provides customers with greater flexibility in sourcing products by enabling them to choose new suppliers and integrate them into their supply chain faster and more cost effectively, and it helps them to manage these relationships more efficiently, enhancing revenue while lowering working capital, labor costs and reducing waste.

 

The Company’s services are delivered though proprietary software products designed, developed, marketed, and supported by the Company. These products provide visibility and facilitate improved business processes among all key constituents in the supply chain, starting with the retailer and moving backwards to suppliers and eventually to raw material providers.

 

The Company provides cloud-based applications and services that address e-commerce, supply chain, food safety, compliance and traceability activities. The principal customers for the Company’s products are household name multi-store food retail chains and restaurants including their suppliers, branded food manufacturers, food wholesalers and distributors, and other food service businesses.

 

The Company has a hub and spoke business model. The Company is typically engaged by retailers and wholesalers (“Hubs”), which in turn require their suppliers (“Spokes”) to utilize the Company’s services.

 

On December 21, 2023, the Company effected a change of its corporate name from Park City Group, Inc. to ReposiTrak, Inc. The Company is incorporated in the State of Nevada and has two principal subsidiaries: PC Group, Inc., a Utah corporation (98.76% owned) (“PCG Utah”) and Park City Group, Inc., a Delaware corporation (100% owned) (“PCG Delaware” and together with PCG Utah, the “Subsidiaries”). All intercompany transactions and balances have been eliminated in the Company’s consolidated financial statements, which contain the operating results of the operations. The Company has no business operations separate from the operations conducted through its Subsidiaries.

 

The Company’s principal executive offices are located at 5282 South Commerce Drive, Suite D292, Murray, Utah 84107. Its telephone number is (435) 645-2000. Its website address is www.repositrak.com.

 

 

Basis of Financial Statement Presentation

 

The interim financial information of the Company as of December 31, 2023 and for the three and six months ended December 31, 2023 is unaudited, and the balance sheet as of June 30, 2023 is derived from audited financial statements. The accompanying condensed consolidated financial statements have been prepared in accordance with United States generally accepted accounting principles ("U.S. GAAP") for interim financial statements. Accordingly, they omit or condense notes and certain other information normally included in financial statements prepared in accordance with U.S. GAAP. The accounting policies followed for quarterly financial reporting conform with the accounting policies disclosed in the Notes to Financial Statements included in our Annual Report on Form 10-K for the year ended June 30, 2023. In the opinion of management, all adjustments necessary for a fair presentation of the financial information for the interim periods reported have been made. All such adjustments are of a normal recurring nature. The results of operations for the six months ended December 31, 2023 are not necessarily indicative of the results that can be expected for the fiscal year ending June 30, 2024. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended June 30, 2023.

v3.24.0.1
Note 2 - Significant Accounting Policies
3 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Significant Accounting Policies [Text Block]

NOTE 2.

SIGNIFICANT ACCOUNTING POLICIES

 

Principles of Consolidation

 

The financial statements presented herein reflect the consolidated financial position of ReposiTrak, Inc. and our subsidiaries. All inter-company transactions and balances have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that materially affect the amounts reported in the consolidated financial statements. Actual results could differ from these estimates. The methods, estimates, and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results it reports in its financial statements. The U.S. Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as those that are most important to the portrayal of the Company’s financial condition and results and require the Company to make its most difficult and subjective judgments, often because of the need to make estimates of matters that are inherently uncertain. Based on this definition, the Company’s most critical accounting policies include revenue recognition, goodwill, other long-lived asset valuations, income taxes, stock-based compensation, and capitalization of software development costs.

 

Revenue Recognition

 

The Company recognizes revenue as it transfers control of deliverables (products, solutions and services) to its customers in an amount reflecting the consideration to which it expects to be entitled. To recognize revenue, the Company applies the following five step approach: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied. The Company accounts for a contract based on the terms and conditions the parties agree to, if the contract has commercial substance and if collectability of consideration is probable. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience.

 

The Company may enter into arrangements that consist of multiple performance obligations. Such arrangements may include any combination of its deliverables. To the extent a contract includes multiple promised deliverables, the Company applies judgment to determine whether promised deliverables are capable of being distinct and are distinct in the context of the contract. If these criteria are not met, the promised deliverables are accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, the Company allocates consideration among the performance obligations based on their relative standalone selling price. Standalone selling price is the price at which the Company would sell a promised good or service separately to the customer. When not directly observable, the Company typically estimates standalone selling price by using the expected cost plus a margin approach. The Company typically establishes a standalone selling price range for its deliverables, which is reassessed on a periodic basis or when facts and circumstances change.

 

For performance obligations where control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The selection of the method to measure progress towards completion requires judgment and is based on the nature of the deliverables to be provided. Revenue related to fixed-price contracts for application development and systems integration services, consulting or other technology services is recognized as the service is performed using the output method, under which the total value of revenue is recognized based on each contract’s deliverable(s) as they are completed and when value is transferred to a customer. Revenue related to fixed-price application maintenance, testing and business process services is recognized based on our right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in FASB ASC Topic 606, Revenue from Contracts with Customers (“Topic 606”), paragraph 606-10-55-18 (“ASC 606-10-55-18”).

 

 

If the Company’s invoicing is not consistent with the value delivered, revenue is recognized as the service is performed based on the method described above. The output method measures the results achieved and value transferred to a customer, which is updated as the project progresses to reflect the latest available information; such estimates and changes in estimates involve the use of judgment. The cumulative impact of any revision in estimates is reflected in the financial reporting period in which the change in estimate becomes known and any anticipated losses on contracts are recognized immediately. Revenue related to fixed-price hosting and infrastructure services is recognized based on the Company’s right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in ASC 606-10-55-18. If the Company’s invoicing is not consistent with value delivered, revenue is recognized on a straight-line basis unless revenue is earned and obligations are fulfilled in a different pattern. The revenue recognition method applied to the types of contracts described above provides the most faithful depiction of performance towards satisfaction of the Company’s performance obligations.

 

Revenue related to the Company’s software license arrangements that do not require significant modification or customization of the underlying software is recognized when the software is delivered as control is transferred at a point in time. For software license arrangements that require significant functionality enhancements or modification of the software, revenue for the software license and related services is recognized as the services are performed in accordance with the methods described above. In software hosting arrangements, the rights provided to the customer, such as ownership of a license, contract termination provisions and the feasibility of the client to operate the software, are considered in determining whether the arrangement includes a license or a service. Revenue related to software maintenance and support is generally recognized on a straight-line basis over the contract period.

 

Management expects that incremental commission fees paid as a result of obtaining a contract are recoverable and therefore the Company capitalized them as contract costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less.

 

Revenue related to transaction-based or volume-based contracts is recognized over the period the services are provided in a manner that corresponds with the value transferred to the customer to-date relative to the remaining services to be provided.

 

From time to time, the Company may enter into arrangements with third party suppliers to resell products or services. In such cases, the Company evaluates whether the Company is the principal (i.e., report revenue on a gross basis) or agent (i.e., report revenue on a net basis). In doing so, the Company first evaluates whether it controls the good or service before it is transferred to the customer. If the Company controls the good or service before it is transferred to the customer, the Company is the principal; if not, the Company is the agent. Determining whether the Company controls the good or service before it is transferred to the customer may require judgment.

 

The Company provides customers with assurance that the related deliverable will function as the parties intended because it complies with agreed-upon specifications. General updates or patch fixes are not considered an additional performance obligation in the contract.

 

Variable consideration is estimated using either the sum of probability weighted amounts in a range of possible consideration amounts (expected value), or the single most likely amount in a range of possible consideration amounts (most likely amount), depending on which method better predicts the amount of consideration to which we may be entitled. The Company includes in the transaction price variable consideration only to the extent it is probable that a significant reversal of revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company’s estimates of variable consideration and determination of whether to include estimated amounts in the transaction price may involve judgment and is based largely on an assessment of its anticipated performance and all information that is reasonably available to the Company.

 

The Company assesses the timing of the transfer of goods or services to the customer as compared to the timing of payments to determine whether a significant financing component exists. As a practical expedient, the Company does not assess the existence of a significant financing component when the difference between payment and transfer of deliverables is a year or less. If the difference in timing arises for reasons other than the provision of finance to either the customer or us, no financing component is deemed to exist. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing its services, not to receive or provide financing from or to customers. The Company does not consider set up or transition fees paid upfront by its customers to represent a financing component, as such fees are required to encourage customer commitment to the project and protect us from early termination of the contract.

 

 

Trade Accounts Receivable and Contract Balances

 

We classify our right to consideration in exchange for deliverables as either a receivable or a contract asset (unbilled receivable). A receivable is a right to consideration that is unconditional (i.e. only the passage of time is required before payment is due). For example, we recognize a receivable for revenue related to our transaction or volume-based contracts when earned regardless of whether amounts have been billed. We present such receivables in trade accounts receivable, net in our consolidated statements of financial position at their net estimated realizable value. We maintain an allowance for doubtful accounts to provide for the estimated amount of receivables that may not be collected. The allowance is based upon an assessment of customer creditworthiness, historical payment experience, the age of outstanding receivables, judgment, and other applicable factors.

 

A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented in current and other assets in our consolidated balance sheets and primarily relate to unbilled amounts on fixed-price contracts utilizing the output method of revenue recognition. The table below shows movements in contract assets:

 

   

Contract

assets

 

Balance – June 30, 2023

  $ 295,011  

Revenue recognized during the period but not billed

    -  

Amounts reclassified to accounts receivable

    (10,000

)

Other

    (26,779

)

Balance – December 31, 2023

  $ 258,232 (1)

 

 

(1)

Contract asset balances for December 31, 2023 include a current and a long-term contract asset of $150,180 and $108,052, respectively.

 

Our contract assets and liabilities are reported at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

The table below shows movements in the deferred revenue balances (current and noncurrent) for the period:

 

   

Contract

liability

 

Balance – June 30, 2023

  $ 1,903,001  

Amounts billed but not recognized as revenue

    885,218  

Revenue recognized related to the opening balance of deferred revenue

    (761,654

)

Balance – December 31, 2023

  $ 2,026,565  

 

Our contract assets and liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

Disaggregation of Revenue

 

The table below presents disaggregated revenue from contracts with customers by contract-type. We believe this disaggregation best depicts the nature, amount, timing and uncertainty of our revenue and cash flows that may be affected by industry, market, and other economic factors:

 

   

Three Months Ended

   

Six Months Ended

 
   

December 31,

   

December 31,

 
   

2023

   

2022

   

2023

   

2022

 
                                 
Recurring revenue – subscription and support services   $ 5,124,751     $ 4,743,216     $ 10,171,436     $ 9,421,193  

Non-recurring revenue – setup and training services

    1,000       7,297       14,427       49,797  
    $ 5,125,751     $ 4,750,513     $ 10,185,863     $ 9,470,990  

 

 

Earnings Per Share

 

Basic net income per share of Common Stock (“Basic EPS”) excludes dilution and is computed by dividing net income applicable to Common Stockholders by the weighted average number of Common Stock outstanding during the period. Diluted net income per share of Common Stock (“Diluted EPS”) reflects the potential dilution that could occur if stock options or other contracts to issue shares of Common Stock were exercised or converted into Common Stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an antidilutive effect on net income per share of Common Stock.

 

For the three and six months ended December 31, 2023 and 2022, warrants to purchase 23,737 shares of our common stock at an exercise price of $10.00 per share were anti-dilutive and not included in the computation of diluted earnings per share because the exercise price of the options was greater than the average price of common stock for the quarter.

 

The following table presents the components of the computation of basic and diluted earnings per share for the periods indicated:

 

   

Three Months Ended

   

Six Months Ended

 
   

December 31,

   

December 31,

 
   

2023

   

2022

   

2023

   

2022

 

Numerator

                               

Net income applicable to common shareholders

  $ 1,304,538     $ 1,118,733     $ 2,536,475     $ 2,257,234  
                                 

Denominator

                               

Weighted average common shares outstanding, basic

    18,162,000       18,402,000       18,193,000       18,419,000  

Warrants to purchase Common Stock

    643,000       228,000       629,000       259,000  

Weighted average common shares outstanding, diluted

    18,805,000       18,630,000       18,822,000       18,678,000  
                                 

Net income per share

                               

Basic

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  

Diluted

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform with the current year’s presentation. These reclassifications have no impact on the previously reported results.

v3.24.0.1
Note 3 - Equity
3 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Equity [Text Block]

NOTE 3.

EQUITY

 

Restricted Stock Units

 

Restricted

Stock Units

   

Weighted

Average
Grant Date
Fair Value

($/share)

 
                 

Outstanding at June 30, 2023

    907,451     $ 5.30  

Granted

    13,010       9.99  

Vested and issued

    (5,945

)

    5.89  

Forfeited

    -       -  

Outstanding at December 31, 2023

    914,516     $ 5.36  

 

As of December 31, 2023, there were 40,837 restricted stock units outstanding that had vested but for which shares of Common Stock had not yet been issued pursuant to the terms of the applicable agreement.

 

 

As of December 31, 2023, there was approximately $4.9 million of unrecognized stock-based compensation obligations under our equity compensation plans. The stock-based compensation obligation is in connection with certain employment agreements which have a deferral option at the Board’s discretion. At the end of the deferral period, the stock-based compensation expense associated with the obligation is expected to be recognized on a straight-line basis over a period of three years.

 

Warrants

 

Outstanding warrants were issued in connection with private placements of the Company’s Common Stock and with the restructuring of the Series B Preferred that occurred in March of 2018. The following table summarizes information about fixed stock warrants outstanding at December 31, 2023:

 

Warrants Outstanding

at December 31, 2023

   

Warrants Exercisable

at December 31, 2023

 

Range of

exercise

prices

   

Number

Outstanding

   

Weighted

average

remaining
contractual

life (years)

   

Weighted

average

exercise price

   

Number

exercisable

   

Weighted

average

exercise price

 
$ 4.00       1,085,068       2.10     $ 4.00       1,085,068     $ 4.00  
$ 10.00       23,737       2.07     $ 10.00       23,737     $ 10.00  
          1,108,805       2.10     $ 4.13       1,108,805     $ 4.13  

 

During the quarter ended March 31, 2023, the Company’s Board of Directors approved the modification to extend the expiration dates of the Company’s existing January 26, 2023 and February 5, 2023 warrants by an additional three years. Accordingly, all the Company’s outstanding warrants have been extended and are anticipated to expire or be exercised on or before the quarter ending March 31, 2026.

 

Preferred Stock

 

The Company’s articles of incorporation currently authorize the issuance of up to 30,000,000 shares of ‘blank check’ preferred stock, par value $0.01 (“Preferred Stock”), with designations, rights, and preferences as may be determined from time to time by the Company’s Board of Directors, of which 700,000 shares are currently designated as Series B Preferred Stock (“Series B Preferred”) and 550,000 shares are designated as Series B-1 Preferred Stock (“Series B-1 Preferred”). Both classes of Series B Preferred Stock pay dividends at a rate of 7% per annum if paid by the Company in cash, or 9% if paid by the Company by the issuance of additional shares of Series B-1 Preferred, or Series B-1 Preferred, as applicable.

 

Preferred Redemption

 

Section 4 of the Company’s First Amended and Restated Certificate of Designation of the Relative Rights, Powers and Preferences of the Series B-1 Preferred Stock, as amended (the “Series B-1 COD”) provides the Company’s Board of Directors with the right to redeem any or all of the outstanding shares of the Company’s Series B-1 Preferred for a cash payment of $10.70 per share at any time upon providing the holders of Series B-1 Preferred at least ten days written notice that sets forth the date on which the redemption will occur (the “Redemption Notice”).

 

On August 29, 2023, the Board approved the redemption and retirement of its Series B Preferred and Series B-1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”). The Preferred Redemption is to occur over the next three years from August 29, 2023.

 

As of December 31, 2023, a total of 625,375 shares of Series B Preferred and 142,309 shares of Series B-1 Preferred were issued and outstanding.

 

 

The following table provides information about the redemption of the Series B Preferred and Series B-1 Preferred during the six months ended December 31, 2023:

 

   

Series B Preferred and Series B-1 Preferred

 

Period (1)

 

Total
Number of
Shares
Redeemed

   

Price Paid
Per Share

   

Dollars

Expended

by Period

under the

Preferred

Redemption

   

Remaining
Amount
Available
for Future
Preferred Redemption

 

July 1, 2023 – September 30, 2023:

    -     $ 10.70     $ -     $ 8,964,214  

October 1, 2023 – December 31, 2023:

    70,093     $ 10.70     $ 749,995     $ 8,214,219  

Total

    70,093             $ 749,995     $ 8,214,219  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.

 

On August 29, 2023, the Board approved the redemption and retirement of its Series B Preferred and Series B-1 Preferred for their stated value, or $10.70 for each share of Preferred Stock, resulting in an aggregate purchase price of $8,964,214 (the “Preferred Redemption”). The Preferred Redemption is to occur over the next three years from August 29, 2023.

 

The following table provides information about the redemption and retirement of the Series B Preferred and Series B-1 Preferred during the three months ended December 31, 2023:

 

   

Series B Preferred

 

Period (1)

 

Total
Number of
Shares
Redeemed

   

Price Paid
Per Share

   

Dollars

Expended

by Period

under the

Preferred

Redemption

   

Remaining
Amount
Available
for Future
Preferred

Redemption

 

October 1, 2023 – December 31, 2023:

    -     $ 10.70     $ -     $ 6,691,513  

Total

    -             $ -     $ 6,691,513  

 

   

Series B-1 Preferred

 

Period (1)

 

Total
Number of
Shares
Redeemed

   

Price Paid
Per Share

   

Dollars

Expended

by Period

under the

Preferred

Redemption

   

Remaining
Amount
Available
for Future
Preferred

Redemption

 

October 1, 2023 – December 31, 2023:

    70,093     $ 10.70     $ 749,995     $ 1,522,706  

Total

    70,093             $ 749,995     $ 1,522,706  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.

 

Share Repurchase Program

 

On May 9, 2019, our Board of Directors approved the repurchase of up to $4.0 million in shares of our Common Stock, which repurchases may be made in privately negotiated transactions or in the open market at prices per share not exceeding the then-current market prices (the “Share Repurchase Program”). Under the Share Repurchase Program, management has discretion to determine the dollar amount of shares to be repurchased and the timing of any repurchases in compliance with applicable laws and regulations, including Rule 10b-18 of the Exchange Act.

 

On March 17, 2020, the Board, given the extreme uncertainty due to COVID-19 at the time, suspended the Share Repurchase Program.

 

On May 18, 2021, our Board of Directors resumed its Share Repurchase Program, and increased the number of shares of Common Stock available to repurchase under the Share Repurchase Program by an additional $4 million bringing the total number of Common Stock authorized to repurchase under the Share Repurchase Program to $8.0 million.

 

On August 31, 2021, our Board of Directors approved a further increase to its Share Repurchase program to $12.0 million in shares of our Common Stock which added an additional $4 million to the Share Repurchase Program.

 

 

On May 10, 2022, our Board of Directors approved an increase of $9.0 million in the number of shares of Common Stock available to repurchase under the Share Repurchase Program.

 

Since inception of the Share Repurchase Program through December 31, 2023, a total of $21,000,000 in shares of Common Stock have been approved under the Share Repurchase Program, and 2,122,703 shares of Common Stock have been repurchased at an average purchase price of $6.13, resulting in $7,992,206 remaining available to repurchase under the current Share Repurchase Program. From time-to-time, our Board of Directors may authorize further increases to our Share Repurchase Program. In addition, the Share Repurchase Program may also be suspended for periods of time or discontinued at any time, at the Board’s discretion.

 

The following table provides information about repurchases of our Common Stock registered pursuant to Section 12 of the Exchange Act, during the three months ended December 31, 2023:

 

Period (1)

 

Total
Number of
Shares
Purchased

   

Average
Price Paid
Per Share

   

Dollars

Expended

by Period

Under the

Plans or
Programs

   

Remaining
Amount
Available
for Future
Share
Repurchases
Under the
Plans or
Programs

 
July 1, 2023 – September 30, 2023     155,025     $ 8.53     $ 1,322,082     $ 8,185,698  

October 1, 2023 – December 31, 2023:

    22,012     $ 8.79     $ 193,492     $ 7,992,206  

 

(1)

We close our books and records on the last calendar day of each month to align our financial closing with our business processes.

v3.24.0.1
Note 4 - Related Party Transactions
3 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]

NOTE 4.

RELATED PARTY TRANSACTIONS

 

During the six months ended December 31, 2023, the Company continued to be a party to a service agreement (the “Service Agreement”) with Fields Management, Inc. (“FMI”), pursuant to which FMI provided certain executive management services to the Company, including designating Randall K. Fields to perform the functions of President and Chief Executive Officer for the Company. Mr. Fields, FMI’s designated executive, who also serves as the Company’s Chair of the Board of Directors, controls FMI. The Company had no payables to FMI under the Service Agreement as of December, 2023 or 2022. During the six months ended December 31, 2023 and 2022, the Company paid FMI $484,902 and $462,030, respectively, in connection with the Service Agreement.

 

During the six months ended December 31, 2023, the Company, the Company redeemed and retired $749,995 in Series B-1 Preferred from Mr. Randall K. Fields, affiliates of Mr. Fields, and Robert W. Allen. Mr. Allen is a director of the Company.

v3.24.0.1
Note 5 - Recent Accounting Pronouncements
3 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Accounting Standards Update and Change in Accounting Principle [Text Block]

NOTE 5.

RECENT ACCOUNTING PRONOUNCEMENTS

 

The Company has reviewed newly issued accounting pronouncements and concluded that they are either not applicable to its business or that no material effect is expected on its consolidated condensed financial statements as a result of future adoption.

v3.24.0.1
Note 6 - Subsequent Events
3 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Subsequent Events [Text Block]

NOTE 6.

SUBSEQUENT EVENTS

 

In accordance with the Subsequent Events Topic of the FASB ASC 855, we have evaluated subsequent events through the filing date and determined that no subsequent events occurred that were reasonably expected to impact the consolidated condensed financial statements presented herein.

 

v3.24.0.1
Significant Accounting Policies (Policies)
3 Months Ended
Dec. 31, 2023
Accounting Policies [Abstract]  
Consolidation, Policy [Policy Text Block]

Principles of Consolidation

 

The financial statements presented herein reflect the consolidated financial position of ReposiTrak, Inc. and our subsidiaries. All inter-company transactions and balances have been eliminated in consolidation.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

 

The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that materially affect the amounts reported in the consolidated financial statements. Actual results could differ from these estimates. The methods, estimates, and judgments the Company uses in applying its most critical accounting policies have a significant impact on the results it reports in its financial statements. The U.S. Securities and Exchange Commission (“SEC”) has defined the most critical accounting policies as those that are most important to the portrayal of the Company’s financial condition and results and require the Company to make its most difficult and subjective judgments, often because of the need to make estimates of matters that are inherently uncertain. Based on this definition, the Company’s most critical accounting policies include revenue recognition, goodwill, other long-lived asset valuations, income taxes, stock-based compensation, and capitalization of software development costs.

Revenue [Policy Text Block]

Revenue Recognition

 

The Company recognizes revenue as it transfers control of deliverables (products, solutions and services) to its customers in an amount reflecting the consideration to which it expects to be entitled. To recognize revenue, the Company applies the following five step approach: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when a performance obligation is satisfied. The Company accounts for a contract based on the terms and conditions the parties agree to, if the contract has commercial substance and if collectability of consideration is probable. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience.

 

The Company may enter into arrangements that consist of multiple performance obligations. Such arrangements may include any combination of its deliverables. To the extent a contract includes multiple promised deliverables, the Company applies judgment to determine whether promised deliverables are capable of being distinct and are distinct in the context of the contract. If these criteria are not met, the promised deliverables are accounted for as a combined performance obligation. For arrangements with multiple distinct performance obligations, the Company allocates consideration among the performance obligations based on their relative standalone selling price. Standalone selling price is the price at which the Company would sell a promised good or service separately to the customer. When not directly observable, the Company typically estimates standalone selling price by using the expected cost plus a margin approach. The Company typically establishes a standalone selling price range for its deliverables, which is reassessed on a periodic basis or when facts and circumstances change.

 

For performance obligations where control is transferred over time, revenue is recognized based on the extent of progress towards completion of the performance obligation. The selection of the method to measure progress towards completion requires judgment and is based on the nature of the deliverables to be provided. Revenue related to fixed-price contracts for application development and systems integration services, consulting or other technology services is recognized as the service is performed using the output method, under which the total value of revenue is recognized based on each contract’s deliverable(s) as they are completed and when value is transferred to a customer. Revenue related to fixed-price application maintenance, testing and business process services is recognized based on our right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in FASB ASC Topic 606, Revenue from Contracts with Customers (“Topic 606”), paragraph 606-10-55-18 (“ASC 606-10-55-18”).

 

 

If the Company’s invoicing is not consistent with the value delivered, revenue is recognized as the service is performed based on the method described above. The output method measures the results achieved and value transferred to a customer, which is updated as the project progresses to reflect the latest available information; such estimates and changes in estimates involve the use of judgment. The cumulative impact of any revision in estimates is reflected in the financial reporting period in which the change in estimate becomes known and any anticipated losses on contracts are recognized immediately. Revenue related to fixed-price hosting and infrastructure services is recognized based on the Company’s right to invoice for services performed for contracts in which the invoicing is representative of the value being delivered, in accordance with the practical expedient in ASC 606-10-55-18. If the Company’s invoicing is not consistent with value delivered, revenue is recognized on a straight-line basis unless revenue is earned and obligations are fulfilled in a different pattern. The revenue recognition method applied to the types of contracts described above provides the most faithful depiction of performance towards satisfaction of the Company’s performance obligations.

 

Revenue related to the Company’s software license arrangements that do not require significant modification or customization of the underlying software is recognized when the software is delivered as control is transferred at a point in time. For software license arrangements that require significant functionality enhancements or modification of the software, revenue for the software license and related services is recognized as the services are performed in accordance with the methods described above. In software hosting arrangements, the rights provided to the customer, such as ownership of a license, contract termination provisions and the feasibility of the client to operate the software, are considered in determining whether the arrangement includes a license or a service. Revenue related to software maintenance and support is generally recognized on a straight-line basis over the contract period.

 

Management expects that incremental commission fees paid as a result of obtaining a contract are recoverable and therefore the Company capitalized them as contract costs. The Company recognizes the incremental costs of obtaining contracts as an expense when incurred if the amortization period of the asset that the Company otherwise would have recognized is one year or less.

 

Revenue related to transaction-based or volume-based contracts is recognized over the period the services are provided in a manner that corresponds with the value transferred to the customer to-date relative to the remaining services to be provided.

 

From time to time, the Company may enter into arrangements with third party suppliers to resell products or services. In such cases, the Company evaluates whether the Company is the principal (i.e., report revenue on a gross basis) or agent (i.e., report revenue on a net basis). In doing so, the Company first evaluates whether it controls the good or service before it is transferred to the customer. If the Company controls the good or service before it is transferred to the customer, the Company is the principal; if not, the Company is the agent. Determining whether the Company controls the good or service before it is transferred to the customer may require judgment.

 

The Company provides customers with assurance that the related deliverable will function as the parties intended because it complies with agreed-upon specifications. General updates or patch fixes are not considered an additional performance obligation in the contract.

 

Variable consideration is estimated using either the sum of probability weighted amounts in a range of possible consideration amounts (expected value), or the single most likely amount in a range of possible consideration amounts (most likely amount), depending on which method better predicts the amount of consideration to which we may be entitled. The Company includes in the transaction price variable consideration only to the extent it is probable that a significant reversal of revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. The Company’s estimates of variable consideration and determination of whether to include estimated amounts in the transaction price may involve judgment and is based largely on an assessment of its anticipated performance and all information that is reasonably available to the Company.

 

The Company assesses the timing of the transfer of goods or services to the customer as compared to the timing of payments to determine whether a significant financing component exists. As a practical expedient, the Company does not assess the existence of a significant financing component when the difference between payment and transfer of deliverables is a year or less. If the difference in timing arises for reasons other than the provision of finance to either the customer or us, no financing component is deemed to exist. The primary purpose of the Company’s invoicing terms is to provide customers with simplified and predictable ways of purchasing its services, not to receive or provide financing from or to customers. The Company does not consider set up or transition fees paid upfront by its customers to represent a financing component, as such fees are required to encourage customer commitment to the project and protect us from early termination of the contract.

 

Receivable [Policy Text Block]

Trade Accounts Receivable and Contract Balances

 

We classify our right to consideration in exchange for deliverables as either a receivable or a contract asset (unbilled receivable). A receivable is a right to consideration that is unconditional (i.e. only the passage of time is required before payment is due). For example, we recognize a receivable for revenue related to our transaction or volume-based contracts when earned regardless of whether amounts have been billed. We present such receivables in trade accounts receivable, net in our consolidated statements of financial position at their net estimated realizable value. We maintain an allowance for doubtful accounts to provide for the estimated amount of receivables that may not be collected. The allowance is based upon an assessment of customer creditworthiness, historical payment experience, the age of outstanding receivables, judgment, and other applicable factors.

 

A contract asset is a right to consideration that is conditional upon factors other than the passage of time. Contract assets are presented in current and other assets in our consolidated balance sheets and primarily relate to unbilled amounts on fixed-price contracts utilizing the output method of revenue recognition. The table below shows movements in contract assets:

 

   

Contract

assets

 

Balance – June 30, 2023

  $ 295,011  

Revenue recognized during the period but not billed

    -  

Amounts reclassified to accounts receivable

    (10,000

)

Other

    (26,779

)

Balance – December 31, 2023

  $ 258,232 (1)

 

 

(1)

Contract asset balances for December 31, 2023 include a current and a long-term contract asset of $150,180 and $108,052, respectively.

 

Our contract assets and liabilities are reported at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

The table below shows movements in the deferred revenue balances (current and noncurrent) for the period:

 

   

Contract

liability

 

Balance – June 30, 2023

  $ 1,903,001  

Amounts billed but not recognized as revenue

    885,218  

Revenue recognized related to the opening balance of deferred revenue

    (761,654

)

Balance – December 31, 2023

  $ 2,026,565  

 

Our contract assets and liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. The difference between the opening and closing balances of our contract assets and deferred revenue primarily results from the timing difference between our performance obligations and the customer’s payment. We receive payments from customers based on the terms established in our contracts, which may vary generally by contract type.

 

Disaggregation of Revenue [Policy Text Block]

Disaggregation of Revenue

 

The table below presents disaggregated revenue from contracts with customers by contract-type. We believe this disaggregation best depicts the nature, amount, timing and uncertainty of our revenue and cash flows that may be affected by industry, market, and other economic factors:

 

   

Three Months Ended

   

Six Months Ended

 
   

December 31,

   

December 31,

 
   

2023

   

2022

   

2023

   

2022

 
                                 
Recurring revenue – subscription and support services   $ 5,124,751     $ 4,743,216     $ 10,171,436     $ 9,421,193  

Non-recurring revenue – setup and training services

    1,000       7,297       14,427       49,797  
    $ 5,125,751     $ 4,750,513     $ 10,185,863     $ 9,470,990  

 

Earnings Per Share, Policy [Policy Text Block]

Earnings Per Share

 

Basic net income per share of Common Stock (“Basic EPS”) excludes dilution and is computed by dividing net income applicable to Common Stockholders by the weighted average number of Common Stock outstanding during the period. Diluted net income per share of Common Stock (“Diluted EPS”) reflects the potential dilution that could occur if stock options or other contracts to issue shares of Common Stock were exercised or converted into Common Stock. The computation of Diluted EPS does not assume exercise or conversion of securities that would have an antidilutive effect on net income per share of Common Stock.

 

For the three and six months ended December 31, 2023 and 2022, warrants to purchase 23,737 shares of our common stock at an exercise price of $10.00 per share were anti-dilutive and not included in the computation of diluted earnings per share because the exercise price of the options was greater than the average price of common stock for the quarter.

 

The following table presents the components of the computation of basic and diluted earnings per share for the periods indicated:

 

   

Three Months Ended

   

Six Months Ended

 
   

December 31,

   

December 31,

 
   

2023

   

2022

   

2023

   

2022

 

Numerator

                               

Net income applicable to common shareholders

  $ 1,304,538     $ 1,118,733     $ 2,536,475     $ 2,257,234  
                                 

Denominator

                               

Weighted average common shares outstanding, basic

    18,162,000       18,402,000       18,193,000       18,419,000  

Warrants to purchase Common Stock

    643,000       228,000       629,000       259,000  

Weighted average common shares outstanding, diluted

    18,805,000       18,630,000       18,822,000       18,678,000  
                                 

Net income per share

                               

Basic

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  

Diluted

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  

 

Reclassification [Policy Text Block]

Reclassifications

 

Certain prior year amounts have been reclassified to conform with the current year’s presentation. These reclassifications have no impact on the previously reported results.

v3.24.0.1
Note 2 - Significant Accounting Policies (Tables)
3 Months Ended
Dec. 31, 2023
Notes Tables  
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
   

Contract

assets

 

Balance – June 30, 2023

  $ 295,011  

Revenue recognized during the period but not billed

    -  

Amounts reclassified to accounts receivable

    (10,000

)

Other

    (26,779

)

Balance – December 31, 2023

  $ 258,232 (1)
   

Contract

liability

 

Balance – June 30, 2023

  $ 1,903,001  

Amounts billed but not recognized as revenue

    885,218  

Revenue recognized related to the opening balance of deferred revenue

    (761,654

)

Balance – December 31, 2023

  $ 2,026,565  
Disaggregation of Revenue [Table Text Block]
   

Three Months Ended

   

Six Months Ended

 
   

December 31,

   

December 31,

 
   

2023

   

2022

   

2023

   

2022

 
                                 
Recurring revenue – subscription and support services   $ 5,124,751     $ 4,743,216     $ 10,171,436     $ 9,421,193  

Non-recurring revenue – setup and training services

    1,000       7,297       14,427       49,797  
    $ 5,125,751     $ 4,750,513     $ 10,185,863     $ 9,470,990  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   

Three Months Ended

   

Six Months Ended

 
   

December 31,

   

December 31,

 
   

2023

   

2022

   

2023

   

2022

 

Numerator

                               

Net income applicable to common shareholders

  $ 1,304,538     $ 1,118,733     $ 2,536,475     $ 2,257,234  
                                 

Denominator

                               

Weighted average common shares outstanding, basic

    18,162,000       18,402,000       18,193,000       18,419,000  

Warrants to purchase Common Stock

    643,000       228,000       629,000       259,000  

Weighted average common shares outstanding, diluted

    18,805,000       18,630,000       18,822,000       18,678,000  
                                 

Net income per share

                               

Basic

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  

Diluted

  $ 0.07     $ 0.06     $ 0.14     $ 0.12  
v3.24.0.1
Note 3 - Equity (Tables)
3 Months Ended
Dec. 31, 2023
Notes Tables  
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]

Restricted Stock Units

 

Restricted

Stock Units

   

Weighted

Average
Grant Date
Fair Value

($/share)

 
                 

Outstanding at June 30, 2023

    907,451     $ 5.30  

Granted

    13,010       9.99  

Vested and issued

    (5,945

)

    5.89  

Forfeited

    -       -  

Outstanding at December 31, 2023

    914,516     $ 5.36  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

Warrants Outstanding

at December 31, 2023

   

Warrants Exercisable

at December 31, 2023

 

Range of

exercise

prices

   

Number

Outstanding

   

Weighted

average

remaining
contractual

life (years)

   

Weighted

average

exercise price

   

Number

exercisable

   

Weighted

average

exercise price

 
$ 4.00       1,085,068       2.10     $ 4.00       1,085,068     $ 4.00  
$ 10.00       23,737       2.07     $ 10.00       23,737     $ 10.00  
          1,108,805       2.10     $ 4.13       1,108,805     $ 4.13  
Preferred Stock Redemption [Table Text Block]
   

Series B Preferred and Series B-1 Preferred

 

Period (1)

 

Total
Number of
Shares
Redeemed

   

Price Paid
Per Share

   

Dollars

Expended

by Period

under the

Preferred

Redemption

   

Remaining
Amount
Available
for Future
Preferred Redemption

 

July 1, 2023 – September 30, 2023:

    -     $ 10.70     $ -     $ 8,964,214  

October 1, 2023 – December 31, 2023:

    70,093     $ 10.70     $ 749,995     $ 8,214,219  

Total

    70,093             $ 749,995     $ 8,214,219  
   

Series B Preferred

 

Period (1)

 

Total
Number of
Shares
Redeemed

   

Price Paid
Per Share

   

Dollars

Expended

by Period

under the

Preferred

Redemption

   

Remaining
Amount
Available
for Future
Preferred

Redemption

 

October 1, 2023 – December 31, 2023:

    -     $ 10.70     $ -     $ 6,691,513  

Total

    -             $ -     $ 6,691,513  
Share Repurchase Program [Table Text Block]
   

Series B-1 Preferred

 

Period (1)

 

Total
Number of
Shares
Redeemed

   

Price Paid
Per Share

   

Dollars

Expended

by Period

under the

Preferred

Redemption

   

Remaining
Amount
Available
for Future
Preferred

Redemption

 

October 1, 2023 – December 31, 2023:

    70,093     $ 10.70     $ 749,995     $ 1,522,706  

Total

    70,093             $ 749,995     $ 1,522,706  

Period (1)

 

Total
Number of
Shares
Purchased

   

Average
Price Paid
Per Share

   

Dollars

Expended

by Period

Under the

Plans or
Programs

   

Remaining
Amount
Available
for Future
Share
Repurchases
Under the
Plans or
Programs

 
July 1, 2023 – September 30, 2023     155,025     $ 8.53     $ 1,322,082     $ 8,185,698  

October 1, 2023 – December 31, 2023:

    22,012     $ 8.79     $ 193,492     $ 7,992,206  
v3.24.0.1
Note 2 - Significant Accounting Policies (Details Textual) - USD ($)
6 Months Ended 15 Months Ended
Dec. 31, 2022
Dec. 31, 2023
Jun. 30, 2023
Contract with Customer, Asset, after Allowance for Credit Loss, Current   $ 150,180 $ 186,959
Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent   $ 108,052 $ 108,052
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) 23,737 23,737  
Maximum [Member]      
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) $ 10 $ 10  
v3.24.0.1
Note 2 - Significant Accounting Policies - Contract with Customer assets and liabilities (Details)
6 Months Ended
Dec. 31, 2023
USD ($)
Balance $ 295,011
Balance 1,903,001
Revenue recognized during the period but not billed 0
Amounts billed but not recognized as revenue 885,218
Amounts reclassified to accounts receivable (10,000)
Revenue recognized related to the opening balance of deferred revenue (761,654)
Other (26,779)
Balance 2,026,565
Balance $ 258,232 [1]
[1] Contract asset balances for December 31, 2023 include a current and a long-term contract asset of $150,180 and $108,052, respectively.
v3.24.0.1
Note 2 - Significant Accounting Policies - Schedule of Disaggregation of Revenue (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Revenue $ 5,125,751 $ 4,750,513 $ 10,185,863 $ 9,470,990
Revenue 5,125,751 4,750,513 10,185,863 9,470,990
Subscription and Support [Member]        
Revenue 5,124,751 4,743,216 10,171,436 9,421,193
Revenue 5,124,751 4,743,216 10,171,436 9,421,193
Professional Services [Member]        
Revenue 1,000 7,297 14,427 49,797
Revenue $ 1,000 $ 7,297 $ 14,427 $ 49,797
v3.24.0.1
Note 2 - Significant Accounting Policies - Schedule of Earnings Per Share (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Net income applicable to common shareholders $ 1,304,538 $ 1,118,733 $ 2,536,475 $ 2,257,234
Weighted average shares, basic (in shares) 18,162,000 18,402,000 18,193,000 18,419,000
Warrants to purchase Common Stock (in shares) 643,000 228,000 629,000 259,000
Weighted average shares, diluted (in shares) 18,805,000 18,630,000 18,822,000 18,678,000
Basic (in dollars per share) $ 0.07 $ 0.06 $ 0.14 $ 0.12
Diluted (in dollars per share) $ 0.07 $ 0.06 $ 0.14 $ 0.12
v3.24.0.1
Note 3 - Equity (Details Textual) - USD ($)
3 Months Ended 55 Months Ended
May 10, 2022
Aug. 31, 2021
May 18, 2021
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2023
Aug. 29, 2023
Jun. 30, 2023
May 09, 2019
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount       $ 4,900,000   $ 4,900,000      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)       3 years          
Preferred Stock, Shares Authorized (in shares)       30,000,000   30,000,000   30,000,000  
Preferred Stock, Par or Stated Value Per Share (in dollars per share)       $ 0.01   $ 0.01   $ 0.01  
Preferred Stock, Redemption Price Per Share (in dollars per share)             $ 10.7    
Preferred Stock, Redemption, Aggerate Purchase Price       $ 8,214,219   $ 8,214,219 $ 8,964,214    
Stock Repurchase Program, Authorized Amount   $ 12,000,000 $ 8,000,000 $ 21,000,000,000,000   $ 21,000,000,000,000     $ 4,000,000
Stock Repurchase Program, Increase in Authorized Amount $ 9,000,000 $ 4,000,000 $ 4,000,000            
Stock Repurchased During Period, Shares (in shares)       22,012 [1] 155,025 2,122,703      
Shares Acquired, Average Cost Per Share       $ 8.79 [1] $ 8.53 $ 6.13      
Stock Repurchase Program, Remaining Authorized Repurchase Amount       $ 7,992,206   $ 7,992,206      
Blank Check [Member]                  
Preferred Stock, Shares Authorized (in shares)       30,000,000   30,000,000      
Preferred Stock, Par or Stated Value Per Share (in dollars per share)       $ 0.01   $ 0.01      
Series B Preferred Stock [Member]                  
Preferred Stock, Shares Authorized (in shares)       700,000   700,000   700,000  
Preferred Stock, Shares, Number (in shares)       700,000          
Preferred Stock, Redemption Price Per Share (in dollars per share) [2]       $ 10.7   $ 10.7      
Preferred Stock, Redemption, Aggerate Purchase Price [2]       $ 6,691,513   $ 6,691,513      
Preferred Stock, Shares Issued (in shares)       625,375   625,375   625,375  
Series B-1 Preferred Stock [Member]                  
Preferred Stock, Shares Authorized (in shares)       550,000   550,000   550,000  
Preferred Stock, Shares, Number (in shares)       550,000          
Preferred Stock, Cash, Dividend Rate, Percentage       7.00%          
Preferred Stock, Series B Preferred Shares, Dividend Rate, Percentage       9.00%          
Preferred Stock, Redemption Price Per Share (in dollars per share) [3]       $ 10.7   $ 10.7      
Preferred Stock, Redemption, Aggerate Purchase Price [3]       $ 1,522,706   $ 1,522,706      
Preferred Stock, Shares Issued (in shares)       142,309   142,309   212,402  
Restricted Stock Units (RSUs) [Member] | Vested and Unissued [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number (in shares)       40,837   40,837      
[1] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
[2] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
[3] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
v3.24.0.1
Note 3 - Equity - Schedule of Restricted Stock Units (Details) - Share-Based Payment Arrangement, Nonemployee [Member]
6 Months Ended
Dec. 31, 2023
$ / shares
shares
Granted (in shares) | shares 13,010
Restricted Stock [Member]  
Outstanding (in shares) | shares 907,451
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares $ 5.3
Restricted Stock Units (RSUs) [Member]  
Granted, weighted average grant date fair value (in dollars per share) | $ / shares $ 9.99
Vested and issued (in shares) | shares (5,945)
Vested and issued, weighted average grant date fair value (in dollars per share) | $ / shares $ 5.89
Forfeited (in shares) | shares 0
Forfeited, weighted average grant date fair value (in dollars per share) | $ / shares $ 0
Outstanding (in shares) | shares 914,516
Outstanding, weighted average grant date fair value (in dollars per share) | $ / shares $ 5.36
v3.24.0.1
Note 3 - Equity - Schedule of Warrants (Details)
6 Months Ended
Dec. 31, 2023
$ / shares
shares
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 4.13
Class of Warrant or Right, Outstanding (in shares) | shares 1,108,805
Class of Warrant or Right, Weighted Average Remaining Contractual Term (Year) 2 years 1 month 6 days
Class of Warrant or Right, Warrants, Exercisable, Number (in shares) | shares 1,108,805
Class of Warrant or Right, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 4.13
Exercise Price, Four Dollars, Minimum [Member]  
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 4
Class of Warrant or Right, Outstanding (in shares) | shares 1,085,068
Class of Warrant or Right, Weighted Average Remaining Contractual Term (Year) 2 years 1 month 6 days
Class of Warrant or Right, Warrants, Exercisable, Number (in shares) | shares 1,085,068
Class of Warrant or Right, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 4
Exercise Price, Ten Dollars, Maximum [Member]  
Class of Warrant or Right, Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 10
Class of Warrant or Right, Outstanding (in shares) | shares 23,737
Class of Warrant or Right, Weighted Average Remaining Contractual Term (Year) 2 years 25 days
Class of Warrant or Right, Warrants, Exercisable, Number (in shares) | shares 23,737
Class of Warrant or Right, Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 10
v3.24.0.1
Note 3 - Equity - Preferred Stock Redemption (Details) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Sep. 30, 2023
[1],[2]
Dec. 31, 2023
Aug. 29, 2023
Total number of shares redeemed (in shares) 70,093     70,093  
Price paid per share (in dollars per share)         $ 10.7
Dollars Expended by Period under the Preferred Redemption $ 749,995 $ 749,995   $ 749,995  
Remaining Amount Available for Future Preferred Redemption $ 8,214,219 $ 8,214,219   $ 8,214,219 $ 8,964,214
Series B and Series B-1 Preferred Stock [Member]          
Total number of shares redeemed (in shares)   70,093 0    
Price paid per share (in dollars per share) $ 10.7 $ 10.7 $ 10.7 $ 10.7  
Dollars Expended by Period under the Preferred Redemption $ 749,995 $ 749,995 $ 0 $ 749,995  
Remaining Amount Available for Future Preferred Redemption $ 8,214,219 $ 8,214,219 $ 8,964,214 $ 8,214,219  
Series B Preferred Stock [Member]          
Price paid per share (in dollars per share) [1] $ 10.7 $ 10.7   $ 10.7  
Remaining Amount Available for Future Preferred Redemption [1] $ 6,691,513 $ 6,691,513   $ 6,691,513  
[1] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
[2] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
v3.24.0.1
Note 3 - Equity - Shares Repurchase Program (Details) - USD ($)
3 Months Ended 6 Months Ended 55 Months Ended
Dec. 31, 2023
Dec. 31, 2023
Sep. 30, 2023
Dec. 31, 2023
Dec. 31, 2023
Aug. 29, 2023
Total number of shares redeemed (in shares) 70,093     70,093    
July 1, 2023 – September 30, 2023 (in shares)   22,012 [1] 155,025   2,122,703  
Price paid per share (in dollars per share)           $ 10.7
July 1, 2023 – September 30, 2023 (in dollars per share)   $ 8.79 [1] $ 8.53   $ 6.13  
Dollars Expended by Period under the Preferred Redemption $ 749,995 $ 749,995   $ 749,995 $ 749,995  
Remaining Amount Available for Future Preferred Redemption 8,214,219 8,214,219   8,214,219 8,214,219 $ 8,964,214
July 1, 2023 – September 30, 2023 7,992,206 $ 7,992,206   7,992,206 7,992,206  
Share Repurchase Program [Member]            
July 1, 2023 – September 30, 2023 (in shares)   193,492 [1] 1,322,082      
July 1, 2023 – September 30, 2023 $ 7,992,206 [1] $ 7,992,206 [1] $ 8,185,698 $ 7,992,206 [1] $ 7,992,206 [1]  
Series B-1 Preferred Stock [Member]            
Total number of shares redeemed (in shares) [2]   70,093        
Price paid per share (in dollars per share) [2] $ 10.7 $ 10.7   $ 10.7 $ 10.7  
Dollars Expended by Period under the Preferred Redemption [2] $ 749,995 $ 749,995   $ 749,995 $ 749,995  
Remaining Amount Available for Future Preferred Redemption [2] $ 1,522,706 $ 1,522,706   $ 1,522,706 $ 1,522,706  
[1] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
[2] We close our books and records on the last calendar day of each month to align our financial closing with our business processes.
v3.24.0.1
Note 4 - Related Party Transactions (Details Textual) - USD ($)
3 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Preferred Stock Value Redemption Amount $ 749,995  
Series B-1 Preferred Stock [Member]    
Preferred Stock Value Redemption Amount 749,995  
Related Party [Member]    
Accounts Payable 0 $ 0
FMI [Member] | Service Agreements [Member]    
Related Party Transaction, Amounts of Transaction $ 484,902 $ 462,030

Park City (NASDAQ:PCYG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Park City Charts.
Park City (NASDAQ:PCYG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Park City Charts.